"CodeSystem Code","CodeSystem Name","Valueset Category Name","Valueset Name","Concept Code","Concept Name"
" 2.16.840.1.113883.6.12","CPT-4","Drug abuse information sensitivity","Substance-Abuse-Procedure-CPT-4","S9475","Ambulatory setting substance abuse treatment or detoxification services, per diem"
" 2.16.840.1.113883.6.12","CPT-4","Drug abuse information sensitivity","Substance-Abuse-Procedure-CPT-4","H0014","Alcohol and/or drug services; ambulatory detoxification"
" 2.16.840.1.113883.6.12","CPT-4","Drug abuse information sensitivity","Substance-Abuse-Procedure-CPT-4","H0013","Alcohol and/or drug services; acute detoxification (residential addiction program outpatient)"
" 2.16.840.1.113883.6.12","CPT-4","Drug abuse information sensitivity","Substance-Abuse-Procedure-CPT-4","H0012","Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient)"
" 2.16.840.1.113883.6.12","CPT-4","Drug abuse information sensitivity","Substance-Abuse-Procedure-CPT-4","H0011","Alcohol and/or drug services; acute detoxification (residential addiction program inpatient)"
" 2.16.840.1.113883.6.12","CPT-4","Drug abuse information sensitivity","Substance-Abuse-Procedure-CPT-4","H0010","Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient)"
" 2.16.840.1.113883.6.12","CPT-4","Drug abuse information sensitivity","Substance-Abuse-Procedure-CPT-4","H0009","Alcohol and/or drug services; acute detoxification (hospital inpatient)"
" 2.16.840.1.113883.6.12","CPT-4","Drug abuse information sensitivity","Substance-Abuse-Procedure-CPT-4","H0008","Alcohol and/or drug services; sub-acute detoxification (hospital inpatient)"
" 2.16.840.1.113883.6.12","CPT-4","Drug abuse information sensitivity","Substance-Abuse-Procedure-CPT-4","4306F","Patient counseled regarding psychosocial and pharmacologic treatment options for opioid addiction (SUD)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87906,"Infectious Agent Genotype Analysis By Nucleic Acid (Dna Or Rna); HIV-1, Other Region (Eg, Integrase, Fusion)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87904,"Infectious Agent Phenotype Analysis By Nucleic Acid (Dna Or Rna) With Drug Resistance Tissue Culture Analysis, HIV 1; Each Additional Drug Tested (List Separately In Addition To Code For Primary Procedure)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87903,"Infectious Agent Phenotype Analysis By Nucleic Acid (Dna Or Rna) With Drug Resistance Tissue Culture Analysis, HIV 1; First Through 10 Drugs Tested"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87901,"Infectious Agent Genotype Analysis By Nucleic Acid (Dna Or Rna); HIV-1, Reverse Transcriptase And Protease Regions"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87900,"Infectious Agent Drug Susceptibility Phenotype Prediction Using Regularly Updated Genotypic Bioinformatics"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87539,"Infectious Agent Detection By Nucleic Acid (Dna Or Rna); HIV-2, Reverse Transcription And Quantification"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87538,"Infectious Agent Detection By Nucleic Acid (Dna Or Rna); HIV-2, Reverse Transcription And Amplified Probe Technique"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87537,"Infectious Agent Detection By Nucleic Acid (Dna Or Rna); HIV-2, Direct Probe Technique"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87536,"Infectious Agent Detection By Nucleic Acid (Dna Or Rna); HIV-1, Reverse Transcription And Quantification"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87535,"Infectious Agent Detection By Nucleic Acid (Dna Or Rna); HIV-1, Reverse Transcription And Amplified Probe Technique"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87534,"Infectious Agent Detection By Nucleic Acid (Dna Or Rna); HIV-1, Direct Probe Technique"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87391,"Infectious Agent Antigen Detection By Enzyme Immunoassay Technique, Qualitative Or Semiquantitative, Multiple-Step Method; HIV-2"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87390,"Infectious Agent Antigen Detection By Enzyme Immunoassay Technique, Qualitative Or Semiquantitative, Multiple-Step Method; HIV-1"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",87389,"Infectious Agent Antigen Detection By Enzyme Immunoassay Technique, Qualitative Or Semiquantitative, Multiple-Step Method; HIV-1 Antigen(S), With HIV-1 And HIV-2 Antibodies, Single Result"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",86703,"Antibody; HIV-1 And HIV-2, Single Result"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",86702,"Antibody; HIV-2"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",86701,"Antibody; HIV-1"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4",86689,"Antibody; Htlv Or HIV Antibody, Confirmatory Test (Eg, Western Blot)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","4293F","Patient Screened For High-Risk Sexual Behavior (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","4290F","Patient Screened For Injection Drug Use (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","4280F","Pneumocystis Jiroveci Pneumonia Prophylaxis Prescribed Within 3 Months Of Low Cd4+ Cell Count Or Percentage (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","4279F","Pneumocystis Jiroveci Pneumonia Prophylaxis Prescribed (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","4276F","Potent Antiretroviral Therapy Prescribed (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","4274F","Influenza Immunization Administered Or Previously Received (HIV) (P-Esrd)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","4271F","Patient Receiving Potent Antiretroviral Therapy For Less Than 6 Months Or Not Receiving Potent Antiretroviral Therapy (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","4270F","Patient Receiving Potent Antiretroviral Therapy For 6 Months Or Longer (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","4149F","Hepatitis B Vaccine Injection Administered Or Previously Received (Hep-C, HIV) (Ibd)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3515F","Patient Has Documented Immunity To Hepatitis C (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3514F","Hepatitis C Screening Documented As Performed (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3513F","Hepatitis B Screening Documented As Performed (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3512F","Syphilis Screening Documented As Performed (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3511F","Chlamydia And Gonorrhea Screenings Documented As Performed (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3510F","Documentation That Tuberculosis (Tb) Screening Test Performed And Results Interpreted (HIV) (Ibd)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3503F","HIV Rna Viral Load Not Below Limits Of Quantification (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3502F","HIV Rna Viral Load Below Limits Of Quantification (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3500F","Cd4+ Cell Count Or Cd4+ Cell Percentage Documented As Performed (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3498F","Cd4+ Cell Percentage >= 15% (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3497F","Cd4+ Cell Percentage <15% (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3496F","Cd4+ Cell Count >= 500 Cells/Mm3 (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3495F","Cd4+ Cell Count 200 - 499 Cells/Mm3 (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3494F","Cd4+ Cell Count < 200 Cells/Mm3 (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3493F","No History Of Nadir Cd4+ Cell Count < 350 Cells/Mm3 And No History Of AIDS-Defining Condition (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3492F","History Of Nadir Cd4+ Cell Count < 350 Cells/Mm3 (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3491F","HIV Indeterminate (Infants Of Undetermined HIV Status Born Of HIV-Infected Mothers) (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3490F","History Of AIDS-Defining Condition (HIV)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","3292F","HIV Testing Ordered Or Documented And Reviewed During The First Or Second Prenatal Visit (Pre-Cr)"
" 2.16.840.1.113883.6.12","CPT-4","HIV/AIDS information sensitivity","HIV-Related-Procedures-CPT-4","0575F","HIV Rna Control Plan Of Care, Documented (HIV)"
"HCPCS","HCPCS","HIV/AIDS information sensitivity","HIV-Related-Procedures-HCPCS","S3645","Hiv-1 antibody testing of oral mucosal transudate"
"HCPCS","HCPCS","HIV/AIDS information sensitivity","HIV-Related-Procedures-HCPCS","G8500","All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient"
"HCPCS","HCPCS","HIV/AIDS information sensitivity","HIV-Related-Procedures-HCPCS","G8491","I intend to report the hiv/aids measures group"
"HCPCS","HCPCS","HIV/AIDS information sensitivity","HIV-Related-Procedures-HCPCS","G0435","Infectious Agent Antigen Detection By Rapid Antibody Test Of Oral Mucosa Transudate, HIV-1 Or HIV-2, Screening"
"HCPCS","HCPCS","HIV/AIDS information sensitivity","HIV-Related-Procedures-HCPCS","G0433","Infectious Agent Antibody Detection By Enzyme-Linked Immunosorbent Assay (Elisa) Technique, HIV-1 And/Or HIV-2, Screening"
"HCPCS","HCPCS","HIV/AIDS information sensitivity","HIV-Related-Procedures-HCPCS","G0432","Infectious Agent Antibody Detection By Enzyme Immunoassay (Eia) Technique, HIV-1 And/Or HIV-2, Screening"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F19.99","Other psychoactive substance use, unspecified with unspecified psychoactive substance-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F19.97","Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F19.96","Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F19.951","Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F19.950","Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F19.94","Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F19.939","Other psychoactive substance use, unspecified with withdrawal, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F19.921","Other psychoactive substance use, unspecified with intoxication with delirium"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.988 ","Other stimulant use, unspecified with other stimulant-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.982 ","Other stimulant use, unspecified with stimulant-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.981 ","Other stimulant use, unspecified with stimulant-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.980 ","Other stimulant use, unspecified with stimulant-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.959 ","Other stimulant use, unspecified with stimulant-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.922 ","Other stimulant use, unspecified with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.288 ","Other stimulant dependence with other stimulant-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.282 ","Other stimulant dependence with stimulant-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.281 ","Other stimulant dependence with stimulant-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.280 ","Other stimulant dependence with stimulant-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.259 ","Other stimulant dependence with stimulant-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.222 ","Other stimulant dependence with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.21","Other stimulant dependence, in remission"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.20","Other stimulant dependence, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.188 ","Other stimulant abuse with other stimulant-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.182 ","Other stimulant abuse with stimulant-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.181 ","Other stimulant abuse with stimulant-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.180 ","Other stimulant abuse with stimulant-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.159 ","Other stimulant abuse with stimulant-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.122 ","Other stimulant abuse with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Stimulant-Abuse-ICD-10","F15.10","Other stimulant abuse, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.99","Other psychoactive substance use, unspecified with unspecified psychoactive substance-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.988 ","Other psychoactive substance use, unspecified with other psychoactive substance-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.982 ","Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.981 ","Other psychoactive substance use, unspecified with psychoactive substance-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.980 ","Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.97","Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.96","Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.959 ","Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.951","Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.950","Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.94","Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.939","Other psychoactive substance use, unspecified with withdrawal, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.922 ","Other psychoactive substance use, unspecified with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.921","Other psychoactive substance use, unspecified with intoxication with delirium"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.288 ","Other psychoactive substance dependence with other psychoactive substance-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.282 ","Other psychoactive substance dependence with psychoactive substance-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.281 ","Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.280 ","Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.259 ","Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.222 ","Other psychoactive substance dependence with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.21","Other psychoactive substance dependence, in remission"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.20","Other psychoactive substance dependence, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.188 ","Other psychoactive substance abuse with other psychoactive substance-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.182 ","Other psychoactive substance abuse with psychoactive substance-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.181 ","Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.180 ","Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.159 ","Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.122 ","Other psychoactive substance abuse with intoxication with perceptual disturbances"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Antidepressant-Other-Mixed-Drug-Abuse-ICD-10","F19.10","Other psychoactive substance abuse, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.988 ","Cannabis use, unspecified with other Cannabis-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.980 ","Cannabis use, unspecified with anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.959 ","Cannabis use, unspecified with psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.922 ","Cannabis use, unspecified with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.90","Cannabis use, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.288 ","Cannabis dependence with other Cannabis-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.280 ","Cannabis dependence with Cannabis-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.259 ","Cannabis dependence with psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.222 ","Cannabis dependence with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.21","Cannabis dependence, in remission"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.20","Cannabis dependence, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.188 ","Cannabis abuse with other Cannabis-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.180 ","Cannabis abuse with Cannabis-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.159 ","Cannabis abuse with psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.122 ","Cannabis abuse with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-10","F12.10","Cannabis abuse, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.988 ","Cocaine use, unspecified with other cocaine-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.982 ","Cocaine use, unspecified with cocaine-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.981 ","Cocaine use, unspecified with cocaine-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.980 ","Cocaine use, unspecified with cocaine-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.959 ","Cocaine use, unspecified with cocaine-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.922 ","Cocaine use, unspecified with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.288 ","Cocaine dependence with other cocaine-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.282 ","Cocaine dependence with cocaine-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.281 ","Cocaine dependence with cocaine-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.280 ","Cocaine dependence with cocaine-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.259 ","Cocaine dependence with cocaine-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.222 ","Cocaine dependence with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.21","Cocaine dependence, in remission"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.20","Cocaine dependence, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.188 ","Cocaine abuse with other cocaine-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.182","Cocaine abuse with cocaine-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.181 ","Cocaine abuse with cocaine-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.180 ","Cocaine abuse with cocaine-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.159 ","Cocaine abuse with cocaine-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-10","F14.122 ","Cocaine abuse with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.988 ","Hallucinogen use, unspecified with other hallucinogen-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.983 ","Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks)"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.980 ","Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.959 ","Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.288 ","Hallucinogen dependence with other hallucinogen-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.283 ","Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks)"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.280 ","Hallucinogen dependence with hallucinogen-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.259 ","Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.21","Hallucinogen dependence, in remission"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.20","Hallucinogen dependence, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.188 ","Hallucinogen abuse with other hallucinogen-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.183 ","Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks)"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.180 ","Hallucinogen abuse with hallucinogen-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.159 ","Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.122 ","Hallucinogen abuse with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-10","F16.10","Hallucinogen abuse, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.988 ","Inhalant use, unspecified with other inhalant-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.982 ","Inhalant use, unspecified with inhalant-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.980 ","Inhalant use, unspecified with inhalant-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.959 ","Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.288 ","Inhalant dependence with other inhalant-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.282 ","Inhalant dependence with inhalant-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.280 ","Inhalant dependence with inhalant-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.259 ","Inhalant dependence with inhalant-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.21","Inhalant dependence, in remission"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.20","Inhalant dependence, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.188 ","Inhalant abuse with other inhalant-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.182 ","Inhalant abuse with inhalant-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.180 ","Inhalant abuse with inhalant-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.159 ","Inhalant abuse with inhalant-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Inhalant-Drug-Abuse-ICD-10","F18.10","Inhalant abuse, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.988 ","Opioid use, unspecified with other opioid-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.982 ","Opioid use, unspecified with opioid-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.981 ","Opioid use, unspecified with opioid-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.959 ","Opioid use, unspecified with opioid-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.922 ","Opioid use, unspecified with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.288 ","Opioid dependence with other opioid-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.282 ","Opioid dependence with opioid-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.281 ","Opioid dependence with opioid-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.259 ","Opioid dependence with opioid-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.222 ","Opioid dependence with intoxication with perceptual disturbance"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.21","Opioid dependence, in remission"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.20","Opioid dependence, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.188 ","Opioid abuse with other opioid-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.182","Opioid abuse with opioid-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.181 ","Opioid abuse with opioid-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.159 ","Opioid abuse with opioid-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-10","F11.10","Opioid abuse, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.988 ","Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.982 ","Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.981 ","Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.980 ","Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.959 ","Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.288 ","Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.282 ","Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.281 ","Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.280 ","Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.259 ","Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.21","Sedative, hypnotic, or anxiolytic dependence, in remission"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.20","Sedative, hypnotic, or anxiolytic dependence, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.188 ","Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.182 ","Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.181 ","Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.180 ","Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.159 ","Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-10","F13.10","Sedative, hypnotic, or anxiolytic abuse, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.982 ","Alcohol use, unspecified with alcohol-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.980 ","Alcohol use, unspecified with alcohol-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.96","Alcohol use, unspecified with alcohol-induced persisting amnestic disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.959 ","Alcohol use, unspecified with alcohol-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.951","Alcohol use, unspecified with alcohol-induced psychotic disorder with hallucinations"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.950","Alcohol use, unspecified with alcohol-induced psychotic disorder with delusion"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.929","Alcohol use, unspecified with intoxication, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.288 ","Alcohol dependence with other alcohol-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.282 ","Alcohol dependence with alcohol-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.281 ","Alcohol dependence with alcohol-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.280 ","Alcohol dependence with alcohol-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.27","Alcohol dependence with alcohol-induced persisting dementia"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.259 ","Alcohol dependence with alcohol-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.239","Alcohol dependence with withdrawal, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.231","Alcohol dependence with withdrawal delirium"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.229","Alcohol dependence with intoxication, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.21","Alcohol dependence, in remission"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.20","Alcohol dependence, uncomplicated"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.188 ","Alcohol abuse with other alcohol-induced disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.182","Alcohol abuse with alcohol-induced sleep disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.181 ","Alcohol abuse with alcohol-induced sexual dysfunction"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.180 ","Alcohol abuse with alcohol-induced anxiety disorder"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.159 ","Alcohol abuse with alcohol-induced psychotic disorder, unspecified"
"ICD-10-CM ","ICD-10-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-10","F10.10","Alcohol abuse, uncomplicated"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Abuse-ICD-9",305.73,"Amphetamine or related acting sympathomimetic abuse, in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Abuse-ICD-9",305.72,"Amphetamine or related acting sympathomimetic abuse, episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Abuse-ICD-9",305.71,"Amphetamine or related acting sympathomimetic abuse, continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Abuse-ICD-9",305.7,"Amphetamine or related acting sympathomimetic abuse, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Abuse-ICD-9",304.43,"Amphetamine and other psychostimulant dependence, in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Abuse-ICD-9",304.42,"Amphetamine and other psychostimulant dependence , episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Abuse-ICD-9",304.41,"Amphetamine and other psychostimulant dependence, continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Abuse-ICD-9",304.4,"Amphetamine and other psychostimulant dependence, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Amphetamine-Abuse-ICD-9",304.4,"Amphetamine and other psychostimulant dependence"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-9",305.23,"Cannabis abuse-in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-9",305.22,"Cannabis abuse-episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-9",305.21,"Cannabis abuse-continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-9",305.2,"Nondependent Cannabis abuse"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-9",304.33,"Cannabis dependence, in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-9",304.32,"Cannabis dependence , episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-9",304.31,"Cannabis dependence, continuousa"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-9",304.3,"Cannabis t dependence"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cannabis-Abuse-ICD-9",292.2,"Pathological drug intoxication"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-9-SNOMED",305.63,"Cocaine abuse-in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-9-SNOMED",305.62,"Cocaine abuse-episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-9-SNOMED",305.61,"Cocaine abuse-continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-9-SNOMED",305.6,"Cocaine Abuse, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-9-SNOMED",305.6,"Nondependent cocaine abuse"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-9-SNOMED",304.23,"Cocaine dependence, in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-9-SNOMED",304.22,"Cocaine dependence , episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-9-SNOMED",304.21,"Cocaine dependence, continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-9-SNOMED",304.2,"Cocaine dependence, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Cocaine-Abuse-ICD-9-SNOMED",304.2,"Cocaine dependence"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292.9,"Unspecified drug-induced mental disorders"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292.89,"Other specified drug-induced mental disorders"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292.85,"Drug induced sleep disorders"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292.84,"Drug-induced mood disorder"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292.83,"Drug-induced persisting amnestic disorder"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292.82,"Drug-induced persisting dementia"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292.81,"Drug-induced delirium"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292.8,"Other specified drug-induced mental disorders"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292.2,"Pathological drug intoxication"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292.12,"Drug-induced psychotic disorders with hallucinations"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292.11,"Drug-induced psychotic disorders with delusions"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292.1,"Drug-induced psychotic disorders"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292,"Drug withdrawal"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Drug-Induced-Mental-Disorders-ICD-9",292,"Drug-induced mental disorders"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-9",305.33,"Hallucinogen abuse-in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-9",305.32,"Hallucinogen abuse-episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-9",305.31,"Hallucinogen abuse-continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-9",305.3,"Hallucinogen Abuse, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-9",305.3,"Nondependent hallucinogen abuse"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-9",304.53,"Hallucinogen dependence, in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-9",304.52,"Hallucinogen dependence , episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-9",304.51,"Hallucinogen dependence, continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-9",304.5,"Hallucinogen dependence, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Hallucinogen-Abuse-ICD-9",304.5,"Hallucinogen and other psychostimulantt dependence"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Inhalant-Other-Mixed-Drug-Abuse-ICD-9",305.93,"Other, mixed, or unspecified drug abuse, in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Inhalant-Other-Mixed-Drug-Abuse-ICD-9",305.92,"Other, mixed, or unspecified drug abuse, episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Inhalant-Other-Mixed-Drug-Abuse-ICD-9",305.91,"Other, mixed, or unspecified drug abuse, continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Inhalant-Other-Mixed-Drug-Abuse-ICD-9",305.9,"Other, mixed, or unspecified drug abuse, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Inhalant-Other-Mixed-Drug-Abuse-ICD-9",305.9,"Nondependent other mixed or unspecified drug abuse"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Inhalant-Other-Mixed-Drug-Abuse-ICD-9",304.63,"Other specified drug dependence, in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Inhalant-Other-Mixed-Drug-Abuse-ICD-9",304.62,"Other specified drug dependence, episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Inhalant-Other-Mixed-Drug-Abuse-ICD-9",304.61,"Other specified drug dependence, continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Inhalant-Other-Mixed-Drug-Abuse-ICD-9",304.6,"Other specified drug dependence, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Inhalant-Other-Mixed-Drug-Abuse-ICD-9",304.6,"Other specified drug dependence"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-9",305.53,"Opioid abuse-in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-9",305.52,"Opioid abuse-episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-9",305.51,"Opioid abuse-continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-9",305.5,"Opioid Abuse, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-9",304.73,"Combinations of opioid type drug with any other drug dependence, in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-9",304.72,"Combinations of opioid type drug with any other drug dependence, episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-9",304.71,"Combinations of opioid type drug with any other drug dependence, continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-9",304.7,"Combinations of opioid type drug with any other drug dependence, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-9",304.03,"Opioid dependence, in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-9",304.02,"Opioid dependence , episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-9",304.01,"Opioid dependence, continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Opioid-Abuse-ICD-9",304,"Opioid dependence, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-9",305.43,"Sedative, hypnotic, or anxiolytic abuse-in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-9",305.42,"Sedative, hypnotic, or anxiolytic abuse-episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-9",305.41,"Sedative, hypnotic, or anxiolytic abuse-continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-9",305.4,"Sedative, hypnotic, or anxiolytic Abuse, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-9",305.4,"Nondependent Sedative, hypnotic, or anxiolytic abuse"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-9",304.13,"Sedative, hypnotic, or anxiolytic dependence, in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-9",304.12,"Sedative, hypnotic, or anxiolytic dependence , episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-9",304.11,"Sedative, hypnotic, or anxiolytic dependence, continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-9",304.1,"Sedative, hypnotic, or anxiolytic dependence, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Sedative-hypnotic-anxiolytic-Abuse-ICD-9",304.1,"Sedative, hypnotic, or anxiolytic dependence"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Substance-Abuse-Procedure-ICD-9",94.69,"Combined alcohol and drug rehabilitation and detoxification"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Substance-Abuse-Procedure-ICD-9",94.68,"Combined alcohol and drug detoxification"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Substance-Abuse-Procedure-ICD-9",94.67,"Combined alcohol and drug rehabilitation"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Substance-Abuse-Procedure-ICD-9",94.66,"Drug rehabilitation and detoxification"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Substance-Abuse-Procedure-ICD-9",94.65,"Drug detoxification"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Substance-Abuse-Procedure-ICD-9",94.64,"Drug rehabilitation"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Substance-Abuse-Procedure-ICD-9",94.63,"Alcohol rehabilitation and detoxification"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Substance-Abuse-Procedure-ICD-9",94.62,"Alcohol detoxification"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Drug abuse information sensitivity","Substance-Abuse-Procedure-ICD-9",94.61,"Alcohol rehabilitation"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","HIV/AIDS information sensitivity","HIV-Related-Disorders-ICD-9-SNOMED","V65.44","Human Immunodeficiency Virus (Hiv) Counseling"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","HIV/AIDS information sensitivity","HIV-Related-Disorders-ICD-9-SNOMED","V15.89","HIV Exposure Possible"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","HIV/AIDS information sensitivity","HIV-Related-Disorders-ICD-9-SNOMED","V08","Hiv Infection, Asymptomatic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","HIV/AIDS information sensitivity","HIV-Related-Disorders-ICD-9-SNOMED",795.71,"Nonspecific serologic evidence of human immunodeficiency virus [HIV]"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","HIV/AIDS information sensitivity","HIV-Related-Disorders-ICD-9-SNOMED",79.53,"Human Immunodeficiency Virus, Type 2 (HIV 2), in Conditions Classified Elsewhere and of Unspecified Site"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","HIV/AIDS information sensitivity","HIV-Related-Disorders-ICD-9-SNOMED","042","Human immunodeficiency virus [HIV] disease"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","HIV/AIDS information sensitivity","HIV-Related-Disorders-ICD-9-SNOMED","042.","Human immunodeficiency virus [HIV] disease"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","HIV/AIDS information sensitivity","HIV-Related-Disorders-ICD-9-SNOMED",294.1,"AIDS Dementia Complex"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",305.03,"Alcohol abuse-in remiss."
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",305.02,"Alcohol abuse-episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",305.01,"Alcohol abuse-continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",305,"Alcohol Abuse, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",305,"Nondependent alcohol abuse"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",303.93,"Other and unspecified alcohol dependence, in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",303.92,"Other and unspecified alcohol dependence , episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",303.91,"Other and unspecified alcohol dependence, continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",303.9,"Other and unspecified alcohol dependence, unspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",303.9,"Other and unspecified alcohol dependence"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",303.03,"Acute alcoholic intoxication in alcoholism, in remission"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",303.02,"Acute alcoholic intoxication in alcoholism, episodic"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",303.01,"Acute alcoholic intoxication in alcoholism, continuous"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",303,"Acute alcoholic intoxication in alcoholism, uspecified"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",303,"Acute alcoholic intoxication"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",303,"Alcohol dependence syndrome"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",291.9,"Unspecified alcohol-induced mental disorders"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",291.89,"Other specified alcohol-induced mental disorders"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",291.82,"Alcohol induced sleep disorders"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",291.81,"Alcohol withdrawal"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",291.5,"Alcohol-induced psychotic disorder with delusions"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",291.4,"Idiosyncratic alcohol intoxication"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",291.3,"Alcohol-induced psychotic disorder with hallucinations"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",291.2,"Alcohol-induced persisting dementia"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",291.1,"Alcohol-induced persisting amnestic disorder"
"2.16.840.1.113883.6.103","ICD-9-Clinical Modification","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",291,"Alcohol withdrawal delirium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP99852-3","Benzylpiperazine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP99793-9","Benzylpiperazine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP71389-8","Chloroamphetamine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP69763-8","Amphetamine+Methamphetamine | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP69733-1","Amphetamine+Methamphetamine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP69732-3","Amphetamine+Methamphetamine | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP69685-3","Amphetamine+Methamphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP54800-5","Amphetamines | Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP54797-3","Amphetamines | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP52056-6","Methamphetamine | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP52053-3","Amphetamines | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP52011-1","Methamphetamine | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP51949-3","Methylenedioxyamphetamine | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP51948-5","Amphetamines | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP51930-3","Methylenedioxymethamphetamine | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP51892-5","Methamphetamine | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP51843-8","Pholedrine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP51821-4","Phendimetrazine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP51734-9","Methylenedianiline | Air"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP51335-5","Methylphenidate | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP51278-7","Furfenorex | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP51273-8","Fenproporex | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP51269-6","Fenetylline | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP50882-7","Clobenzorex | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP50416-4","Alpha-phenyl-2-piperidine Acetate | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP50415-6","Amphetaminil | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP50411-5","Amphetamines | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP50129-3","Dextromethamphetamine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP50128-5","Dextroamphetamine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP49898-7","Alpha-phenyl-2-piperidine Acetate | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP49557-9","Levoamphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP49165-1","Phendimetrazine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP49154-5","Methylenedioxyethylamphetamine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP49150-3","Amphetamine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP49114-9","Amphetamines | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48761-8","Methylenedianiline | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48722-0","Phendimetrazine | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48718-8","Methylenedioxyethylamphetamine | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48704-8","Methylenedioxyamphetamine | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48689-1","Amphetamines | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48678-4","Methylenedioxyamphetamine | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48677-6","Methylenedioxymethamphetamine | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48672-7","Phendimetrazine | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48649-5","Methamphetamine | Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48645-3","Amphetamines | Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48644-6","Phendimetrazine | Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48636-2","Methylenedioxyethylamphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48632-1","Methylenedioxyethylamphetamine | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48631-3","Methylenedioxyethylamphetamine | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48625-5","Methylenedioxyethylamphetamine | Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48573-7","Amphetamine | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48532-3","Amphetamines | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48485-4","Methylenedioxymethamphetamine | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48484-7","Methylenedioxyamphetamine | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48483-9","Amphetamine | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48464-9","Methylenedioxyamphetamine | Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48462-3","Methamphetamine | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48445-8","Phendimetrazine | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP48222-1","Methamphetamine | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP46221-5","Para Hydroxyamphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP46215-7","Methylphenidate | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP46203-3","Dimetamphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP45784-3","Methylenedioxyamphetamine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP45782-7","Methylenedioxymethamphetamine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP45781-9","Methylenedioxyamphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP45310-7","Methylenedianiline | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP45300-8","Methamphetamine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP44655-6","Methamphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP44654-9","Amphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP44639-0","Ethylamphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP44051-8","Methamphetamine | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP43676-3","Methamphetamine | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP43255-6","Amphetamines | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP43225-9","Methylenedioxymethamphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP42699-6","Dextroamphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP42023-9","Levomethamphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP42022-1","Dextromethamphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP41899-3","Amphetamines | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP41878-7","Phenethylamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP31526-4","Amphetamine+Methamphetamine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP29634-0","Alpha-Phenyl-2-Piperidine acetate"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP21172-9","Methylenedioxyethylamphetamine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP19426-3","Dextromethamphetamine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP19292-9","Methylenedioxyamphetamine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP19144-2","Methylenedianiline"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP18868-7","Amphetamine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP18612-9","Methylenedioxymethamphetamine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP18064-3","Phenethylamine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP18019-7","Dextroamphetamine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP163969-1","Methylone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP16254-2","Pholedrine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP16245-0","Phendimetrazine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP16234-4","Para hydroxyamphetamine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP16202-1","Methylphenidate"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP16194-0","Methamphetamine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP16154-4","Furfenorex"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP16147-8","Fenproporex"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP16144-5","Fenetylline"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP16081-9","Clobenzorex"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP16035-5","Amphetaminil"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP16034-8","Amphetamines"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP158117-4","Amphetamine | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP158103-4","Methylenedioxyamphetamine | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP145348-1","2,5-dimethoxy-4-bromoamphetamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP135765-8","Methylenedioxymethamphetamine | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP134010-0","Mephedrone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP102280-7","Alpha-Phenyl-2-Piperidine acetate | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP102275-7","Methylphenidate | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP102274-0","Methylenedioxymethamphetamine | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP102273-2","Methylenedioxyethylamphetamine | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP102260-9","Alpha-Phenyl-2-Piperidine acetate | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP102256-7","Methylphenidate | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP102255-9","Methylenedioxyethylamphetamine | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP102254-2","Methylenedioxyamphetamine | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","LP100108-2","Benzylpiperazine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","9814-5","Dextroamphetamine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","9352-6","Amphetamines [Mass/mass] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8156-2","Amphetamines [Presence] in Unknown substance by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8155-4","Amphetamines [Presence] in Unknown substance by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8154-7","Amphetamines [Presence] in Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8153-9","Amphetamines [Mass/volume] in Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8152-1","Amphetamines [Presence] in Urine by SAMHSA screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8151-3","Amphetamines [Presence] in Urine by SAMHSA confirm method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8150-5","Amphetamines [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8149-7","Amphetamines [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8148-9","Amphetamines [Presence] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8147-1","Amphetamines [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8146-3","Amphetamines [Presence] in Meconium by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8145-5","Amphetamines [Presence] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8144-8","Amphetamines [Presence] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8143-0","Amphetamines [Mass/volume] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8142-2","Amphetamines [Presence] in Gastric fluid by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8141-4","Amphetamines [Presence] in Gastric fluid by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8140-6","Amphetamines [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","8139-8","Amphetamines [Mass/volume] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","73686-8","Methylone [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","72796-6","Mephedrone/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","72795-8","Mephedrone [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","72794-1","Methylone/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","72793-3","Methylone [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","72792-5","Methylphenidate/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","72791-7","Alpha-Phenyl-2-Piperidine acetate/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","72790-9","Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","72758-6","Amphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","72736-2","Methylenedioxyamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","72735-4","Methamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","70138-3","Amphetamines [Mass/volume] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","69798-7","2,5-dimethoxy-4-bromoamphetamine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","69025-5","Methylenedioxymethamphetamine [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","69024-8","Methylenedioxyethylamphetamine [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","69023-0","Methylenedioxyamphetamine [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","69022-2","Methamphetamine [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","67838-3","Mephedrone [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","66127-2","Amphetamine [Presence] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","64233-0","Benzylpiperazine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","64138-1","Methylenedioxyamphetamine/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","64127-4","Methylenedioxyethylamphetamine/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","61090-7","Alpha-Phenyl-2-Piperidine acetate [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","61084-0","Methylphenidate [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","61083-2","Methylenedioxymethamphetamine [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","61082-4","Methylenedioxyethylamphetamine [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","61059-2","Alpha-Phenyl-2-Piperidine acetate [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","61058-4","Alpha-Phenyl-2-Piperidine acetate [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","61050-1","Methylphenidate [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","61049-3","Methylenedioxyethylamphetamine [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","61048-5","Methylenedioxyethylamphetamine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","61047-7","Methylenedioxyethylamphetamine [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","61046-9","Methylenedioxyamphetamine [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","61045-1","Methylenedioxyamphetamine [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","59844-1","Methylenedioxyethylamphetamine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","59837-5","Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","59287-3","Benzylpiperazine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","59286-5","Benzylpiperazine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","59285-7","Benzylpiperazine [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","59135-4","Benzylpiperazine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","58925-9","Dextromethamphetamine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","58358-3","Methamphetamine/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","58357-5","Amphetamine/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","56120-9","Amphetamine+Methamphetamine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","55587-0","Methamphetamine [Moles/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","55552-4","Methylphenidate [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","55551-6","Methylenedioxyamphetamine [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","53821-5","Chloroamphetamine [Mass/volume] in Serum"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","52957-8","Amphetamine [Moles/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","51690-6","Amphetamines [Presence] in Blood by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","48939-3","Amphetamines [Mass/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","45143-5","Methylenedioxyethylamphetamine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","44424-0","Methylenedioxymethamphetamine/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","43983-6","Amphetamines [Presence] in Urine by Screen method >500 ng/mL"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","43934-9","Amphetamines [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","43860-6","Amphetamine+Methamphetamine [Presence] in Gastric fluid by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","42576-9","Amphetamine [Mass/volume] in Blood by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","42253-5","Methylenedioxyamphetamine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","41464-9","Amphetamines/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","40804-7","Methamphetamine [Presence] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","40803-9","Methamphetamine [Presence] in Hair by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","40799-9","Amphetamines [Presence] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","40798-1","Amphetamines [Presence] in Hair by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","40652-0","Methamphetamine [Presence] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","40531-6","Methylenedioxyamphetamine [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","40529-0","Amphetamines [Presence] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","40493-9","Methylenedioxymethamphetamine [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","40481-4","Methylenedioxymethamphetamine [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","40421-0","Amphetamine+Methamphetamine [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","40420-2","Amphetamine+Methamphetamine [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","40419-4","Amphetamine+Methamphetamine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","40381-6","Methamphetamine [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3970-1","Pholedrine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3941-2","Phendimetrazine [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3940-4","Phendimetrazine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3939-6","Phendimetrazine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3938-8","Phendimetrazine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3903-2","Para hydroxyamphetamine [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3902-4","Para hydroxyamphetamine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3901-6","Para hydroxyamphetamine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","38748-0","Methylenedianiline [Mass/volume] in Air"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3810-9","Methylphenidate [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3809-1","Methylphenidate [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3808-3","Methylphenidate [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3807-5","Methylphenidate [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3806-7","Methylphenidate [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3780-4","Methamphetamine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3779-6","Methamphetamine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3778-8","Methamphetamine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3777-0","Methamphetamine [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3776-2","Methamphetamine [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3658-2","Furfenorex [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3657-4","Furfenorex [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3656-6","Furfenorex [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3635-0","Fenproporex [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3634-3","Fenproporex [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3633-5","Fenproporex [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3629-3","Fenetylline [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3628-5","Fenetylline [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3627-7","Fenetylline [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3566-7","Dimetamphetamine [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3565-9","Dimetamphetamine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3564-2","Dimetamphetamine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3489-2","Clobenzorex [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3488-4","Clobenzorex [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","33646-1","Methylenedianiline [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3352-2","Amphetaminil [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3351-4","Amphetaminil [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","33507-5","Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3350-6","Amphetaminil [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3349-8","Amphetamines [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","3348-0","Amphetamines [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","33280-9","Amphetamine+Methamphetamine [Mass/volume] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","33016-7","Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","32643-9","Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","32642-1","Dextroamphetamine/Levoamphetamine [Mass Ratio] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","32153-9","Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","31026-8","Dextromethamphetamine/Amphetamines.total in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","31025-0","Dextroamphetamine/Amphetamines.total in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","31016-9","Levoamphetamine/Amphetamines.total in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","30112-7","Amphetamine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","29619-4","Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","29613-7","Phendimetrazine [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","29599-8","Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","29598-0","Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","29592-3","Amphetamine [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","29530-3","Amphetamines [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","29286-2","Methamphetamine [Presence] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27409-2","Methylenedianiline [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27303-7","Phendimetrazine [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27299-7","Methylenedioxyethylamphetamine [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27289-8","Methamphetamine [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27277-3","Methamphetamine [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27263-3","Amphetamines [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27244-3","Methylenedioxyamphetamine [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27205-4","Amphetamines [Presence] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27189-0","Methylenedioxyamphetamine [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27188-2","Methylenedioxymethamphetamine [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27178-3","Phendimetrazine [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27116-3","Methamphetamine [Mass/volume] in Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27105-6","Amphetamines [Mass/volume] in Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27102-3","Phendimetrazine [Mass/volume] in Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27085-0","Methylenedioxyethylamphetamine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27080-1","Methylenedioxyethylamphetamine [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27079-3","Methylenedioxyethylamphetamine [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","27074-4","Methylenedioxyethylamphetamine [Mass/volume] in Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","26959-7","Amphetamine [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","26895-3","Amphetamines [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","26793-0","Methylenedioxymethamphetamine [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","26792-2","Methylenedioxyamphetamine [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","26791-4","Amphetamine [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","26742-7","Methylenedioxyamphetamine [Mass/volume] in Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","26734-4","Methamphetamine [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","26711-2","Phendimetrazine [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","21386-8","Methamphetamine [Presence] in Urine by SAMHSA confirm method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","20554-2","Para hydroxyamphetamine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","20548-4","Methylphenidate [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","20546-8","Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","20545-0","Methylenedioxyamphetamine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","20526-0","Dimetamphetamine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","20525-2","Dextroamphetamine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","20410-7","Amphetamines [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19654-3","Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19653-5","Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19652-7","Para hydroxyamphetamine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19651-9","Para hydroxyamphetamine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19580-0","Methylphenidate cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19579-2","Methylphenidate cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19578-4","Methylphenidate [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19577-6","Methylphenidate [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19572-7","Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19571-9","Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19570-1","Methylenedioxymethamphetamine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19569-3","Methylenedioxymethamphetamine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19568-5","Methylenedioxymethamphetamine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19567-7","Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19566-9","Methylenedioxyamphetamine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19565-1","Methylenedioxyamphetamine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19557-8","Methamphetamine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19556-0","Methamphetamine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19555-2","Methamphetamine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19554-5","Methamphetamine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19515-6","Levomethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19514-9","Levomethamphetamine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19512-3","Levomethamphetamine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19511-5","Levomethamphetamine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19510-7","Levomethamphetamine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19461-3","Ethylamphetamine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19460-5","Ethylamphetamine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19459-7","Ethylamphetamine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19458-9","Ethylamphetamine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19456-3","Ethylamphetamine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19455-5","Dimetamphetamine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19454-8","Dimetamphetamine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19453-0","Dimetamphetamine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19452-2","Dimetamphetamine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19428-2","Dextromethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19427-4","Dextromethamphetamine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19425-8","Dextromethamphetamine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19424-1","Dextromethamphetamine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19423-3","Dextromethamphetamine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19422-5","Dextroamphetamine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19421-7","Dextroamphetamine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19420-9","Dextroamphetamine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19419-1","Dextroamphetamine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19348-2","Amphetamine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19347-4","Amphetamine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19346-6","Amphetamine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19344-1","Amphetamine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19343-3","Amphetamine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19269-0","Amphetamines confirm method [Identifier] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19268-2","Amphetamines screen method [Identifier] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19267-4","Amphetamines cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19266-6","Amphetamines cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19263-3","Amphetamines tested for in Urine by Screen method Narrative"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19262-5","Amphetamines tested for in Urine by Screen method Nominal"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19261-7","Amphetamines [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","19059-5","Amphetamines cutoff [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","18431-7","Amphetamines [Presence] in Stool by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","18359-0","Methylenedioxyamphetamine [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","18358-2","Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","18357-4","Methylenedioxymethamphetamine [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","18356-6","Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","18355-8","Methylenedioxyamphetamine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","17272-6","Methylenedianiline [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","17260-1","Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","16369-1","Amphetamines [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","16235-4","Methamphetamine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","16234-7","Amphetamine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","16212-3","Ethylamphetamine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","15405-4","Methamphetamine [Mass/volume] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","15404-7","Levomethamphetamine/Amphetamines.total in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","15366-8","Dextroamphetamine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","14834-6","Methamphetamine [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","14309-9","Amphetamines [Presence] in Urine by Confirm method >200 ng/mL"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","14308-1","Amphetamines [Presence] in Urine by Screen method >1000 ng/mL"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","14267-9","Methylenedioxymethamphetamine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","13498-1","Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","13497-3","Dextroamphetamine/Levoamphetamine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","12478-4","Levomethamphetamine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","12477-6","Dextromethamphetamine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","12350-5","Amphetamines [Presence] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Amphetamine-Toxicology-LOINC","12331-5","Phenethylamine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP65459-7","Cannabinoids | Dialysis fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP63561-2","Carboxy Tetrahydrocannabinol | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP63560-4","Cannabinoids | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP63556-2","11-Hydroxy delta-9 tetrahydrocannabinol | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP63097-7","Tetrahydrocannabinol | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP54804-7","Tetrahydrocannabinol | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP54803-9","Tetrahydrocannabinol | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP52978-1","Tetrahydrocannabinol | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP52872-6","Tetrahydrocannabinol | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP52078-0","11-Hydroxy delta-9 tetrahydrocannabinol | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP52054-1","Cannabinoids | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP50443-8","Cannabinoids | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP49616-3","Carboxy Tetrahydrocannabinol | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP49063-8","Carboxy Tetrahydrocannabinol | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP48694-1","Carboxy Tetrahydrocannabinol | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP48637-0","Cannabinoids | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP48601-6","Cannabinoids | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP48512-5","Cannabinoids | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP48468-0","Cannabinoids | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP48461-5","Carboxy Tetrahydrocannabinol | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP46058-1","Carboxy Tetrahydrocannabinol | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP45738-9","Cannabinoids | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP44794-3","Cannabinoids | Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP44656-4","Cannabinoids | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP44610-1","Carboxy Tetrahydrocannabinol | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP42683-0","Tetrahydrocannabinol | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP41902-5","Tetrahydrocannabinol | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP35627-6","11-Hydroxy delta-9 tetrahydrocannabinol"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP182207-3","JWH-073 (synthetic cannabinoid) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP182173-7","UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP181189-4","JWH-200 (synthetic cannabinoid) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP180956-7","JWH-018 pentanoate (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP180938-5","RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP180879-1","JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP180794-2","JWH-122 (synthetic cannabinoid) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP180611-8","RCS-4 (synthetic cannabinoid) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP180426-1","JWH-250 (synthetic cannabinoid) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP180020-2","JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP179864-6","JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP179855-4","JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP179814-1","JWH-018 carboxylated (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP179615-2","JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP179303-5","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP179235-9","Cannabinoids synthetic | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP179179-9","JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP179035-3","JWH-073 butanol (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178806-8","MAM-2201 pentanoate (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178805-0","JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178789-6","UR-144 (synthetic cannabinoid) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178788-8","MAM-2201 pentanoate (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178592-4","UR-144 pentanoate (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178591-6","JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178590-8","JWH-073 (synthetic cannabinoid) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178589-0","JWH-018 (synthetic cannabinoid) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178588-2","JWH-018 (synthetic cannabinoid) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178523-9","UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178489-3","JWH-073 carboxylated (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178378-8","JWH-018 pentanol (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178331-7","JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178330-9","JWH-018 pentanoate (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178329-1","JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178305-1","MAM-2201 (synthetic cannabinoid) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP178154-3","JWH-073 butanoate (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP177768-1","UR-144 pentanoate (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP177683-2","JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP177682-4","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP177659-2","RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP177547-9","JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP177544-6","JWH-250 4/5-hydroxypentyl (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP177416-7","JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP177415-9","JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP177283-1","AM-2201 (synthetic cannabinoid) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP177282-3","JWH-398 (synthetic cannabinoid) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP177281-5","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP177280-7","JWH-073 butanoate (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP176890-4","RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP176889-6","JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP176693-2","RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP176666-8","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP172814-8","UR-144 (synthetic cannabinoid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP172813-0","RCS-4 (synthetic cannabinoid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP172812-2","MAM-2201 (synthetic cannabinoid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP172811-4","JWH-398 (synthetic cannabinoid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP172810-6","JWH-250 (synthetic cannabinoid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP172809-8","JWH-200 (synthetic cannabinoid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP172808-0","JWH-122 (synthetic cannabinoid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP172807-2","AM-2201 (synthetic cannabinoid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP172775-1","JWH-073 (synthetic cannabinoid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP172774-4","JWH-018 (synthetic cannabinoid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP16059-5","Tetrahydrocannabinol"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP16058-7","Cannabinoids"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP158121-6","Carboxy tetrahydrocannabinol | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157591-1","Cannabinoids synthetic | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157300-7","JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157299-1","JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157298-3","UR-144 pentanoate (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157297-5","UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157296-7","MAM-2201 pentanoate (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157295-9","RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157294-2","RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157292-6","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157291-8","JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157290-0","JWH-073 butanoate (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157289-2","JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157288-4","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157287-6","JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157286-8","JWH-018 pentanoate (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157282-7","JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP157281-9","JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP14468-0","Carboxy tetrahydrocannabinol"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP130325-6","Cannabinoids synthetic | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","LP130276-1","Cannabinoids synthetic"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/9/8172","Cannabinoids [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/9/8167","Tetrahydrocannabinol [Presence] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","8176-0","Cannabinoids [Mass/volume] in Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","8162-0","Tetrahydrocannabinol [Mass/volume] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/8/8177","Cannabinoids [Presence] in Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/8/8163","Tetrahydrocannabinol [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","74157-9","Cannabinoids [Presence] in Serum, Plasma or Blood by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73957-3","UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73956-5","JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73955-7","UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73954-0","JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73953-2","JWH-073 (Synthetic cannabinoid) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73952-4","AM-2201 (synthetic cannabinoid) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73951-6","RCS-4 (synthetic cannabinoid) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73950-8","JWH-250 (synthetic cannabinoid) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73949-0","JWH-018 (Synthetic cannabinoid) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73948-2","JWH-122 (Synthetic cannabinoid) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73947-4","JWH-398 (synthetic cannabinoid) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73946-6","JWH-200 (synthetic cannabinoid) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73945-8","UR-144 (synthetic cannabinoid) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73944-1","MAM-2201 (synthetic cannabinoid) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73943-3","Cannabinoids synthetic [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73935-9","Tetrahydrocannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73930-0","RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73929-2","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73928-4","JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73927-6","JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73926-8","JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73925-0","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73924-3","JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73923-5","JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73922-7","RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73921-9","JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73920-1","JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73919-3","MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73918-5","JWH-073 (Synthetic cannabinoid) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73917-7","JWH-250 4/5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","73914-4","JWH-018 (Synthetic cannabinoid) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72875-8","JWH-073 butanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72874-1","JWH-073 butanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72818-8","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72817-0","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72809-7","JWH-018 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72808-9","JWH-018 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72807-1","JWH-073 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72806-3","JWH-073 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72805-5","JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72804-8","JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72803-0","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72802-2","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72783-4","JWH-018 pentanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72782-6","JWH-018 pentanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72781-8","JWH-018 pentanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72780-0","JWH-018 pentanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72779-2","JWH-073 butanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72778-4","JWH-073 butanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72764-4","Carboxy tetrahydrocannabinol [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72474-0","JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72473-2","JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72472-4","UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72471-6","UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72470-8","MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72469-0","RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72468-2","RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72467-4","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72466-6","JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72465-8","JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72464-1","JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72463-3","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72462-5","JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72461-7","JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72460-9","JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72459-1","JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","72379-1","Cannabinoids synthetic [Presence] in Unspecified specimen by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","70178-9","11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","70145-8","Cannabinoids [Presence] in Urine by Screen method >50 ng/mL"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","70144-1","Cannabinoids [Presence] in Urine by Screen method >20 ng/mL"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","70143-3","Cannabinoids [Mass/volume] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/7/8168","Tetrahydrocannabinol [Presence] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/7/3528","Tetrahydrocannabinol [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","69007-3","Carboxy tetrahydrocannabinol [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","67126-3","Cannabinoids synthetic [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","61063-4","Carboxy tetrahydrocannabinol [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","61062-6","Carboxy tetrahydrocannabinol [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/6/8178","Cannabinoids [Presence] in Unknown substance by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/6/8164","Tetrahydrocannabinol [Presence] in Gastric fluid by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/6/3425","Cannabinoids [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","59573-6","Cannabinoids [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","59160-2","Cannabinoids [Mass/mass] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","58047-2","Tetrahydrocannabinol [Presence] in Blood by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","57924-3","Carboxy tetrahydrocannabinol [Presence] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","52954-5","Cannabinoids [Moles/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","51791-2","Tetrahydrocannabinol [Presence] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","50406-8","Cannabinoids [Presence] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","50338-3","Cannabinoids [Mass/volume] in Dialysis fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/5/8174","Tetrahydrocannabinol [Presence] in Urine by SAMHSA confirm method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/5/8169","Tetrahydrocannabinol [Presence] in Meconium by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/5/3435","Carboxy tetrahydrocannabinol [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","49746-1","Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","48944-3","Carboxy tetrahydrocannabinol [Mass/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","48943-5","Cannabinoids [Presence] in Unspecified specimen by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","48942-7","Cannabinoids [Mass/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","48935-1","11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","48934-4","11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","47386-8","Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","44049-5","Tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","43834-1","Tetrahydrocannabinol [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","42860-7","Cannabinoids [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","42630-4","Cannabinoids [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","42492-9","Carboxy tetrahydrocannabinol [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","42491-1","Cannabinoids [Presence] in Blood by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","40864-1","11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","40801-3","Cannabinoids [Presence] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","40800-5","Cannabinoids [Presence] in Hair by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/4/8179","Cannabinoids [Presence] in Unknown substance by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/4/3426","Tetrahydrocannabinol [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","33561-2","Cannabinoids [Mass/volume] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","33282-5","Cannabinoids [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","31136-5","Carboxy tetrahydrocannabinol [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","31080-5","Cannabinoids [Presence] in Meconium by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/3/8170","Cannabinoids [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/3/8165","Tetrahydrocannabinol [Presence] in Gastric fluid by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/3/3530","Tetrahydrocannabinol [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/3/3436","Carboxy tetrahydrocannabinol [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","29326-6","Carboxy tetrahydrocannabinol [Mass/volume] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","27213-8","Carboxy tetrahydrocannabinol [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","27193-2","Tetrahydrocannabinol [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","27086-8","Cannabinoids [Presence] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","27024-9","Cannabinoids [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","26995-1","Carboxy tetrahydrocannabinol [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","26893-8","Tetrahydrocannabinol [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","26856-5","Cannabinoids [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","26764-1","Cannabinoids [Presence] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","26747-6","Cannabinoids/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","26743-5","Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","26732-8","Carboxy tetrahydrocannabinol [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","26731-0","Tetrahydrocannabinol [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","21557-4","Tetrahydrocannabinol [Presence] in Urine by Screen method >100 ng/mL"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","21556-6","Tetrahydrocannabinol [Presence] in Urine by Screen method >20 ng/mL"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","20521-1","Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","20413-1","Cannabinoids [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/2/8175","Tetrahydrocannabinol [Presence] in Urine by SAMHSA screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/2/3427","Cannabinoids [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19418-3","Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19417-5","Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19416-7","Tetrahydrocannabinol [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19415-9","Tetrahydrocannabinol [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19384-7","Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19383-9","Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19382-1","Carboxy tetrahydrocannabinol [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19381-3","Carboxy tetrahydrocannabinol [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19294-8","Cannabinoids confirm method [Identifier] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19293-0","Cannabinoids screen method [Identifier] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19292-2","Cannabinoids cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19291-4","Cannabinoids cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19289-8","Cannabinoids [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19288-0","Cannabinoids tested for in Urine by Screen method Narrative"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19287-2","Cannabinoids tested for in Urine by Screen method Nominal"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19073-6","Cannabinoids cutoff [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","19055-3","Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","18432-5","Tetrahydrocannabinol [Presence] in Stool by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","18282-4","Cannabinoids [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","17872-3","Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","16543-1","Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","16542-3","Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","16243-8","Cannabinoids [Mass/volume] in Blood by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","16150-5","Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","14313-1","Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","14312-3","Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","13478-3","Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","12351-3","Tetrahydrocannabinol [Presence] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/1/8171","Cannabinoids [Presence] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Cannabinoids-Toxicology-LOINC","1/1/8166","Tetrahydrocannabinol [Mass/volume] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP53326-2","2-oxo-3-hydroxy-lysergate diethylamide | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP51310-8","Lysergate Diethylamide | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP51161-5","Dimethyltryptamine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP45825-4","Psilocin | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP45559-9","Tryptamine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP45438-6","Psilocybin | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP45437-8","Psilocybin | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP44641-6","Lysergate Diethylamide | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP44609-3","Psilocin | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP44608-5","Mescaline | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP43534-4","Bufotenine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP41988-4","Bufotenine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP41841-5","Mescaline | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP41840-7","Hallucinogens | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP41836-5","Dimethyltryptamine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP18864-6","Psilocin"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP18049-4","Hallucinogens"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP180335-4","NBOMe | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP180251-3","25H-NBOMe | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP17987-6","Mescaline"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP179577-4","2C-C-NBOMe | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP179484-3","25I-NBOMe | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP179322-5","Lysergate diethylamide | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP178302-8","Lysergate diethylamide | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP173524-2","NBOMe"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP17245-9","Psilocybin"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP16809-3","Bufotenine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP16179-1","Lysergate diethylamide"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP16115-5","Dimethyltryptamine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP102283-1","Lysergate diethylamide | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP102261-7","Lysergate diethylamide | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP100139-7","Salvinorin B | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP100138-9","Salvinorin A | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP100137-1","Salvinorin B | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP100136-3","Salvinorin A | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP100050-6","Salvinorin B"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","LP100049-8","Salvinorin A"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","9726-1","Mescaline [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","74001-9","NBOMe [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","74000-1","25I-NBOMe [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","73999-5","2C-C-NBOMe [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","73998-7","25H-NBOMe [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","73730-4","Lysergate diethylamide [Presence] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","73726-2","Lysergate diethylamide [Presence] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","6930-2","Psilocybin [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","61094-9","Lysergate diethylamide [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","61065-9","Lysergate diethylamide [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","59329-3","Salvinorin B [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","59328-5","Salvinorin A [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","59327-7","Salvinorin B [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","59326-9","Salvinorin A [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","59325-1","Salvinorin B [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","59324-4","Salvinorin A [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","5679-6","Lysergate diethylamide [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","5678-8","Lysergate diethylamide [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","5608-5","Bufotenine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","45185-6","2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","3732-5","Lysergate diethylamide [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","3731-7","Lysergate diethylamide [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","3730-9","Lysergate diethylamide [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","3568-3","Dimethyltryptamine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","3567-5","Dimethyltryptamine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","33350-0","Lysergate diethylamide [Mass/volume] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","20558-3","Psilocin [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","20543-5","Mescaline [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","20542-7","Lysergate diethylamide [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19691-5","Psilocybin cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19690-7","Psilocybin cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19688-1","Psilocybin [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19687-3","Psilocybin [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19686-5","Psilocybin [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19685-7","Psilocin cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19684-0","Psilocin cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19683-2","Psilocin [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19682-4","Psilocin [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19545-3","Mescaline cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19544-6","Mescaline cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19543-8","Mescaline [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19542-0","Mescaline [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19531-3","Lysergate diethylamide cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19530-5","Lysergate diethylamide cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","19528-9","Lysergate diethylamide [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","18415-0","Psilocin [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","18414-3","Psilocin [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","17751-9","Tryptamine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","17505-9","Psilocybin/Psilocin [Mass Ratio] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","17504-2","Psilocybin [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","16214-9","Lysergate diethylamide [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","16146-3","Psilocin [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","16145-5","Mescaline [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","12433-9","Bufotenine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","12296-0","Mescaline [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","12295-2","Hallucinogens [Identifier] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Hallucinogen-Toxicology-LOINC","12292-9","Dimethyltryptamine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP99257-5","Oxycodone+Oxymorphone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP99251-8","Oxycodone+Oxymorphone"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP99229-4","Tapentadol | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP99227-8","Meperidine+Normeperidine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP99226-0","Fentanyl+Norfentanyl | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP99218-7","Tapentadol"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP99216-1","Fentanyl+Norfentanyl"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP97410-2","Codeine | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP97406-0","6-Monoacetylmorphine | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP69828-9","Dihydrocodeine Free+Hydrocodol Free | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP69790-1","Dihydrocodeine Free+Hydrocodol Free | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP69785-1","Methadone+metabolite | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP69751-3","Methadone+metabolite | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP69721-6","Buprenorphine+Norbuprenorphine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP69618-4","Dihydrocodeine+hydrocodeinone | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP69611-9","Dihydrocodeine+hydrocodeinone | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP69363-7","Propoxyphene+acetaminophen | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP67150-0","Meperidine+Normeperidine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP66955-3","Meperidine+Normeperidine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP66670-8","Codeine Free | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP66669-0","Hydrocodone Free | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP66372-1","Dihydrocodeine+hydrocodol | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP64885-4","Normorphine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP64884-7","Norcodeine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP64883-9","Norcodeine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP64857-3","Norcodeine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP63572-9","Norpropoxyphene | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP63009-2","Morphine-3-glucuronide | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP62452-5","Morphine-6-glucuronide | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP57465-4","6-monoacetylmorphine Free | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP57120-5","Oxymorphone Free | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP57119-7","Oxycodone Free | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP57118-9","Hydromorphone Free | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP55150-4","Nalbuphine | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP55136-3","Propoxyphene | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP55021-7","Morphine | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP54999-5","Sufentanil | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP54970-6","Butorphanol | Body Fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP54821-1","Opiates | Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP54818-7","Opiates | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP53508-5","Oxymorphone Free | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP53507-7","Dihydrocodeine+hydrocodol | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP52861-9","Propoxyphene | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP52507-8","Naloxone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP52339-6","2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP52338-8","2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP52337-0","2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP52057-4","Opiates | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP52038-4","Trimeperidine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP52008-7","Hydrocodone | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP52006-1","Codeine | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP51894-1","Morphine | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP51891-7","Hydromorphone | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP51750-5","Opiates | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP51526-9","Nicomorphine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP51491-6","Nalorphine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP51307-4","Levorphanol | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP51287-8","Hydromorphone | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP51286-0","Hydrocodone | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP51204-3","Dipipanone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP51145-8","Meperidine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP51027-8","Dextromoramide | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP50718-3","Methadone.R | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP50660-7","Opiates | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP50446-1","Anileridine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP50444-6","Anileridine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP50429-7","Methadone.long Acting Metabolite | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP50287-9","Alphaprodine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP50286-1","Alfentanil | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49866-4","Oxycodone | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49865-6","Morphine | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49863-1","6-monoacetylmorphine | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49856-5","Meperidine | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49849-0","Hydromorphone | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49848-2","Hydrocodone | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49728-6","Alphaprodine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49594-2","Narcotics and opioids | Bile fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49592-6","Morphine Free | Bile fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49590-0","Methadone | Bile fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49116-4","Methadone | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49090-1","Norpropoxyphene | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49084-4","Narcotics and opioids | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49083-6","Narcotics and opioids | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49079-4","Fentanyl | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49075-2","6-monoacetylmorphine | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49069-5","Morphine Free | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP49053-9","Methadone | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48885-5","Naloxone | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48819-4","Normeperidine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48745-1","Hydrocodone Free | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48730-3","Opiates | Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48729-5","Hydromorphone Free | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48728-7","Hydrocodone Free | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48727-9","Codeine Free | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48716-2","Oxycodone Free | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48693-3","Norpropoxyphene | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48691-7","Methadone | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48690-9","Morphine Free | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48685-9","Hydromorphone Free | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48679-2","Propoxyphene | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48654-5","Opiates | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48618-0","Morphine Free | Cerebral spinal fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48617-2","Morphine | Cerebral spinal fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48616-4","Methadone | Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48611-5","Norpropoxyphene | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48604-0","Norpropoxyphene | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48517-4","Oxycodone | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48515-8","Hydrocodone | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48514-1","Hydromorphone | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48465-6","Opiates | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48454-0","Oxycodone | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48453-2","6-monoacetylmorphine | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48452-4","Codeine | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48451-6","Hydrocodone | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48450-8","Hydromorphone | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP48439-1","Morphine Free | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP46219-9","Morphine Free | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP45844-5","Sufentanil | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP45379-2","Opiates | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP45375-0","Norpropoxyphene | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP45312-3","Methylfentanyl | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP45299-2","Methadone.long Acting Metabolite | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP45076-4","Hydromorphone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP45007-9","Ethylmorphine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44947-7","Nalbuphine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44928-7","Fentanyl | Body Fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44907-1","Diamorphine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44903-0","Propoxyphene | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44902-2","Dextromoramide | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44778-6","Buprenorphine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44701-8","Alfentanil | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44659-8","6-monoacetylmorphine Free | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44645-7","Nalbuphine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44640-8","Levorphanol | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44636-6","Buprenorphine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44632-5","Propoxyphene | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44631-7","Methadone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44630-9","Diamorphine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44033-6","Morphine | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP44031-0","Codeine | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP43870-2","Morphine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP43867-8","Methadone | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP43864-5","Codeine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP43695-3","Oxycodone | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP43682-1","6-monoacetylmorphine | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP43671-4","Meperidine | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP43525-2","Meperidine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP43093-1","Dihydrocodeine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP43092-3","Dihydrocodeine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP42798-6","Morphine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP42793-7","Codeine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP42175-7","Oxycodone Free | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP42174-0","6-monoacetylmorphine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP42173-2","Hydromorphone Free | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP42172-4","Hydrocodone Free | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP42171-6","Dihydrocodeine Free | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP42170-8","Codeine Free | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP42082-5","Narcotics and opioids | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP42078-3","Papaverine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41958-7","6-beta naltrexone | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41946-2","Butorphanol | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41908-2","Propoxyphene | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41907-4","Methadone | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41905-8","Opiates | Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41890-2","Oxymorphone | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41880-3","Butorphanol | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41872-0","Diamorphine | Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41856-3","Naltrexone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41855-5","Hydrocodone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41770-6","Codeine | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41752-4","Oxycodone | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41494-3","Oxymorphone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41492-7","Morphine Free | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41491-9","Methadone | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41482-8","Fentanyl | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41481-0","Propoxyphene | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41320-0","Norfentanyl | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41319-2","Norfentanyl | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41318-4","Despropionylfentanyl | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41317-6","Despropionylfentanyl | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41268-1","Propoxyphene | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41266-5","Methadone | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41242-6","Oxycodone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41240-0","Naltrexone | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP41228-5","6-monoacetylmorphine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP40868-9","Normeperidine | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP40657-6","Opiates | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP40628-7","Norpropoxyphene | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP40489-4","Dihydrocodeine Free+Hydrocodol Free"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP40336-7","Dihydrocodeine+Hydrocodol"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP40335-9","Oxymorphone Free"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP36029-4","Methadone+Metabolite"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP35885-0","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP31478-8","Narcotic antagonists"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP29091-3","Oxycodone Free"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP29067-3","Hydromorphone Free"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP29064-0","Hydrocodone Free"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP29031-9","Codeine Free"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP28863-6","Morphine Free"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP28812-3","6-monoacetylmorphine free"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP28525-1","Naloxone"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP21164-6","Dihydrocodeine+Hydrocodeinone"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP19141-8","Methadone.long acting metabolite"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP182210-7","Acetyl fentanyl | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP18183-1","Dihydrocodeine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP18149-2","Narcotics and opioids"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP18145-0","Papaverine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP18094-0","6-Beta naltrexone"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP180841-1","Meperidine | Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP180693-6","Hydromorphone | Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP180382-6","Morphine | Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP179843-0","Meperidine | Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP17947-0","Propoxyphene + Norpropoxyphene"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP17874-6","Sufentanil"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP17844-9","Butorphanol"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP178270-7","Fentanyl | Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP172593-8","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP163963-4","Mitragynine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP163962-6","7-Hydroxymitragynine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16300-3","Trimeperidine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16217-9","Nicomorphine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16213-8","Nalorphine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16212-0","Nalbuphine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16184-1","Meperidine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16173-4","Levorphanol"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16162-7","Hydromorphone"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16161-9","Hydrocodone"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16139-5","Ethylmorphine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16117-1","Dipipanone"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16107-2","Diamorphine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16106-4","Dextromoramide"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16054-6","Buprenorphine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16036-3","Anileridine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16022-3","Alphaprodine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP16021-5","Alfentanil"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP158126-5","6-Beta naltrexone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP158122-4","Oxymorphone | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP158120-8","Buprenorphine | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP158118-2","Fentanyl | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP158115-8","Hydrocodone | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP158114-1","Morphine | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP158113-3","Meperidine | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP158109-1","Norfentanyl | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP158108-3","Norhydrocodone | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP158107-5","Normeperidine | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP158106-7","Noroxycodone | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP158102-6","Hydromorphone | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP157972-3","Norpropoxyphene | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP157971-5","Propoxyphene + Norpropoxyphene | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP157970-7","Propoxyphene | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP157938-4","Propoxyphene + Norpropoxyphene | Blood-Serum-Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP157928-5","Propoxyphene + Norpropoxyphene | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP157686-9","Mitragynine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP157661-2","Methadone+Metabolite | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP157595-2","Methadone | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP157594-5","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP15176-8","Oxymorphone"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP15174-3","Morphine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP15167-7","Fentanyl"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP15048-9","Norfentanyl"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP15047-1","Despropionylfentanyl"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP15017-4","Propoxyphene"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP15015-8","Methadone"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP15003-4","Oxycodone"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP15000-0","Naltrexone"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP14980-4","6-Monoacetylmorphine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP149566-4","Oxycodone+Oxymorphone | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP14726-1","Normeperidine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP14710-5","Propoxyphene+Acetaminophen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP14565-3","Opiates"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP14549-7","Norpropoxyphene"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP136076-9","Oxycodone | Saliva"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP135764-1","Oxymorphone | Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP133002-8","Tapentadol | Tissue and Smears"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP124893-1","Fentanyl+Norfentanyl | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP121247-3","Nortapentadol | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP102617-0","Norhydrocodone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP102616-2","Noroxycodone | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP102596-6","Norhydrocodone"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP102595-8","Noroxycodone"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP102277-3","Normeperidine | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP102276-5","Norfentanyl | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP102269-0","Fentanyl | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP102268-2","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP102258-3","Normeperidine | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP102257-5","Norfentanyl | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP102252-6","Fentanyl | XXX"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP101457-2","6-Acetylcodeine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP101086-9","Papaverine | Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP100154-6","Tapentadol | Body fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","LP100153-8","Tapentadol | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","9835-0","Hydromorphone [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","8223-0","Opiates [Mass/volume] in Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","8218-0","Opiates [Presence] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",795226,"Trimeperidine [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",794922,"Trimeperidine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",794617,"Trimeperidine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","74383-1","Fentanyl [Mass/volume] in Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","74380-7","Hydromorphone [Mass/volume] in Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","74379-9","Morphine [Mass/volume] in Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","74378-1","Meperidine [Mass/volume] in Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","74372-4","Acetyl fentanyl [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","74167-8","Opiates [Mass/volume] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","74137-1","Norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","74136-3","Fentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","74131-4","Morphine [Mass/volume] in Serum, Plasma or Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","74130-6","6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum, Plasma or Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","74108-2","Meperidine [Presence] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73996-1","Oxycodone [Presence] in Meconium by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73995-3","Mitragynine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73972-2","Morphine Free [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73942-5","Buprenorphine [Presence] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73941-7","6-monoacetylmorphine free [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73940-9","Hydromorphone Free [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73939-1","Hydrocodone Free [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73938-3","Fentanyl [Mass/volume] in Blood by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73937-5","Norfentanyl [Mass/volume] in Blood by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73936-7","Fentanyl [Presence] in Blood by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73934-2","Meperidine [Mass/volume] in Serum, Plasma or Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73933-4","Normeperidine [Mass/volume] in Serum, Plasma or Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73753-6","Oxycodone [Presence] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73729-6","Meperidine [Presence] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73727-0","Methadone [Presence] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73567-0","Propoxyphene [Presence] in Meconium by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","73562-1","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",728051,"Oxycodone [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72789-1","Naltrexone/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72788-3","6-Beta naltrexone/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72787-5","6-Beta naltrexone [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72766-9","Oxymorphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72763-6","6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72762-8","Buprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72760-2","Fentanyl [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72759-4","Codeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72753-7","Hydrocodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72752-9","Morphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72751-1","Oxycodone [Mass/volume] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72750-3","Oxycodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72749-5","Meperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72745-3","Norfentanyl [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72744-6","Norhydrocodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72743-8","Normeperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72742-0","Noroxycodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72734-7","Methadone [Mass/volume] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72733-9","Hydromorphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72732-1","Mitragynine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72731-3","7-Hydroxymitragynine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72730-5","Mitragynine/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72729-7","7-Hydroxymitragynine/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72626-5","Methadone [Presence] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72622-4","Propoxyphene [Presence] in Saliva (oral fluid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72621-6","Propoxyphene [Mass/volume] in Saliva (oral fluid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72620-8","Norpropoxyphene [Presence] in Saliva (oral fluid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72619-0","Norpropoxyphene [Mass/volume] in Saliva (oral fluid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72618-2","Propoxyphene + Norpropoxyphene [Presence] in Saliva (oral fluid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72617-4","Propoxyphene [Presence] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72485-6","Tapentadol [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72475-7","Methadone+Metabolite [Presence] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72402-1","Oxycodone [Presence] in Blood by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72401-3","Propoxyphene [Presence] in Blood by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72400-5","Methadone [Presence] in Blood by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72388-2","Methadone [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72387-4","Methadone [Presence] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72386-6","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72385-8","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Saliva (oral fluid) by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","72384-1","Meperidine+Normeperidine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",722907,"Opiates [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",722603,"Opiates [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",719895,"Norpropoxyphene [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",719589,"Norpropoxyphene [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",719285,"Normeperidine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","71430-3","Oxycodone+Oxymorphone [Presence] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",712649,"Nicomorphine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",709334,"Nalorphine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",709028,"Nalbuphine [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",708724,"Nalbuphine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",708419,"Nalbuphine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",705710,"Morphine [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",705405,"Morphine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",705101,"Morphine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",704798,"Morphine Free [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",704189,"Morphine Free [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",703883,"Morphine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",703579,"Morphine [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","70215-9","Oxycodone [Moles/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","70210-0","Morphine [Moles/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","70206-8","Codeine [Moles/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","70197-9","6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","70151-6","Opiates [Presence] in Urine by Screen method >300 ng/mL"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","70150-8","Opiates [Mass/volume] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","70149-0","Methadone [Presence] in Urine by Screen method >300 ng/mL"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","70148-2","Methadone [Presence] in Urine by Screen method >150 ng/mL"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","70147-4","Methadone [Mass/volume] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","69356-4","Oxycodone [Presence] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","69028-9","Oxymorphone [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","69027-1","Morphine [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","68544-6","Hydrocodone [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","68543-8","Oxycodone [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","68542-0","Codeine [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","68541-2","Hydromorphone [Mass/mass] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",684922,"Methadone [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",684648,"Methadone [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",684345,"Methadone [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",683736,"Methadone [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",683430,"Methadone [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",674970,"Meperidine [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",674664,"Meperidine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",674360,"Meperidine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",674056,"Meperidine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",662307,"Levorphanol [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",662003,"Levorphanol [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",661699,"Levorphanol [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","66130-6","Fentanyl+Norfentanyl [Presence] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","66129-8","Fentanyl+Norfentanyl [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",661091,"Levorphanol [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","65808-8","Nortapentadol [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","65807-0","Tapentadol [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",650896,"Hydromorphone [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",650590,"Hydrocodone [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",650286,"Hydrocodone [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",649981,"Hydrocodone [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","64131-6","Dihydrocodeine/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",634580,"Fentanyl [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",634276,"Fentanyl [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",627944,"Ethylmorphine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",627640,"Ethylmorphine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61429-7","Tapentadol/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61425-5","Noroxycodone [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61424-8","Noroxycodone [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61423-0","Noroxycodone/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61422-2","Norhydrocodone [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61421-4","Norhydrocodone [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61420-6","Norhydrocodone/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",611995,"Dipipanone [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61197-0","Oxycodone+Oxymorphone [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",611418,"Dipipanone [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",611112,"Dipipanone [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61087-3","Normeperidine [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61086-5","Norfentanyl [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61077-4","Fentanyl [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61076-6","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61054-3","Normeperidine [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61053-5","Norfentanyl [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61052-7","Norfentanyl [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","61042-8","Fentanyl [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","60514-7","6-Acetylcodeine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","60467-8","Oxymorphone [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","60330-8","Propoxyphene [Moles/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","60276-3","Oxycodone+Oxymorphone cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",601737,"Diamorphine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",601434,"Diamorphine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","60126-0","Papaverine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","60125-2","Papaverine [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",600826,"Propoxyphene [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","60071-8","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",600246,"Propoxyphene [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",599942,"Propoxyphene [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","59961-3","Propoxyphene [Moles/volume] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","59960-5","Propoxyphene [Moles/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","59944-9","Normeperidine [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","59924-1","Meperidine [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",599030,"Dextromoramide [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","59734-4","Propoxyphene [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","59705-4","Methadone [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","59673-4","Fentanyl [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","59355-8","Tapentadol [Mass/volume] in Tissue"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","59354-1","Tapentadol [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","59353-3","Tapentadol [Mass/volume] in Body fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","59352-5","Tapentadol [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",587555,"Codeine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",586946,"Codeine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",586640,"Codeine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",586336,"Codeine [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58430-0","Oxycodone+Oxymorphone [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58429-2","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58428-4","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58402-9","Tapentadol [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58401-1","Tapentadol [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58399-7","Norpropoxyphene/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58398-9","Propoxyphene/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58396-3","Oxymorphone/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58395-5","Oxycodone/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58394-8","Hydromorphone/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58393-0","Hydrocodone/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58392-2","Morphine/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58391-4","Codeine/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58390-6","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP)/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58389-8","Normeperidine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58388-0","Normeperidine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58387-2","Normeperidine/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58386-4","Meperidine/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58385-6","Meperidine+Normeperidine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58384-9","6-Monoacetylmorphine (6-MAM)/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58383-1","Norfentanyl [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58382-3","Norfentanyl/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58381-5","Fentanyl [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58380-7","Fentanyl/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58379-9","Fentanyl+Norfentanyl [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58360-9","Buprenorphine/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","58359-1","Buprenorphine+Norbuprenorphine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","57982-1","Hydromorphone [Presence] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","57981-3","Hydrocodone [Presence] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","57865-8","Oxycodone [Moles/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","57864-1","Meperidine [Moles/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","57863-3","Hydromorphone [Moles/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","57861-7","Hydrocodone [Moles/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","57304-8","Codeine [Mass/volume] in Saliva (oral fluid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","57300-6","6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid)"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","55574-8","Propoxyphene + Norpropoxyphene [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","55559-9","Norpropoxyphene [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","55537-5","Fentanyl [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","55523-5","Anileridine [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","55520-1","6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",553830,"Buprenorphine [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",553525,"Buprenorphine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",552645,"Buprenorphine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","53846-2","Buprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",533072,"Anileridine [Moles/volume] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",532161,"Anileridine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",531855,"Anileridine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","52958-6","Methadone [Moles/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","52952-9","Opiates [Moles/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","51984-3","Meperidine+Normeperidine [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","51955-3","Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","51954-6","Oxycodone Free [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","51765-6","Dihydrocodeine+Hydrocodol [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","51740-9","6-monoacetylmorphine free [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","51739-1","Codeine Free [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","51738-3","Hydrocodone Free [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","51737-5","Hydromorphone Free [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","51736-7","Oxymorphone Free [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","51691-4","Opiates [Presence] in Blood by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",515571,"Alphaprodine [Mass/time] in 24 hour Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",514660,"Alphaprodine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","51448-9","Dihydrocodeine+Hydrocodol [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",514354,"Alphaprodine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",514049,"Alfentanil [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","50620-4","Opiates cutoff [Mass/mass] in Meconium for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","50542-0","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","50021-5","Oxycodone [Mass/volume] in Serum, Plasma or Blood by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","49831-1","Normorphine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","49830-3","Norcodeine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","49829-5","Norcodeine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","49752-9","Buprenorphine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","49750-3","Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","49749-5","6-monoacetylmorphine free [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","48964-1","Propoxyphene [Mass/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","48963-3","Propoxyphene [Mass/volume] in Unspecified specimen by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","48961-7","Opiates [Mass/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","48960-9","Norpropoxyphene [Mass/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","48957-5","Methadone [Mass/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","48956-7","Methadone [Mass/volume] in Unspecified specimen by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","48403-0","Methadone+Metabolite [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","48365-1","Methadone.R [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","48364-4","Morphine-3-Glucuronide [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","48363-6","Morphine-6-Glucuronide [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","47415-5","Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","47411-4","Methadone [Presence] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","47004-7","6-monoacetylmorphine free [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46975-9","Oxymorphone Free [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46974-2","Oxymorphone Free [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46973-4","Oxycodone Free [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46971-8","Hydromorphone Free [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46704-3","Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46703-5","Dihydrocodeine Free+Hydrocodol Free [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46263-0","6-monoacetylmorphine free [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46262-2","Codeine Free [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46261-4","Hydrocodone Free [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46260-6","Hydromorphone Free [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46259-8","Morphine Free [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46258-0","Oxymorphone Free [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46257-2","Dihydrocodeine+Hydrocodol [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","46256-4","Oxycodone Free [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","45022-1","Methadone+Metabolite [Presence] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","43811-9","Propoxyphene [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","43595-8","Methadone [Presence] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","43200-5","Norfentanyl [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","43199-9","Norfentanyl [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","43184-1","6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","42901-9","Dihydrocodeine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","42618-9","Naloxone [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","42251-9","Methadone+Metabolite [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","41860-8","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","41859-0","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","41858-2","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","41466-4","Methadone/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","41465-6","Opiates/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","41038-1","Codeine [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","40839-3","Fentanyl [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","40806-2","Opiates [Presence] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","40805-4","Opiates [Presence] in Hair by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","40634-8","Hydrocodone [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","40626-4","Codeine [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","40528-2","Opiates [Presence] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","40384-0","Morphine [Presence] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","40369-1","Hydromorphone [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","38373-7","Buprenorphine+Norbuprenorphine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","3744-0","Meperidine [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","3683-0","Hydromorphone [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","35649-3","Propoxyphene [Mass/volume] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","35626-1","Norpropoxyphene [Mass/volume] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","35625-3","Normeperidine [Mass/volume] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","35618-8","Methadone [Mass/volume] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","35617-0","Meperidine [Mass/volume] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","3541-0","Dextromoramide [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","34427-5","Methadone.R [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","34177-6","Opiates [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","3414-0","Buprenorphine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","33527-3","Methadone.long acting metabolite [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","3310-0","Alphaprodine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","32125-7","Propoxyphene [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","32101-8","Oxycodone [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","32100-0","Morphine [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","32099-4","6-Monoacetylmorphine (6-MAM) [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","32093-7","Methadone [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","32088-7","Meperidine [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","32081-2","Hydromorphone [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","32080-4","Hydrocodone [Presence] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","31088-8","Narcotics and opioids [Identifier] in Bile fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","31086-2","Morphine Free [Mass/volume] in Bile fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","31084-7","Methadone [Mass/volume] in Bile fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29400-9","Meperidine [Mass/volume] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29387-8","Norpropoxyphene [Mass/volume] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29377-9","Narcotics and opioids [Identifier] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29376-1","Narcotics and opioids [Identifier] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29372-0","Codeine [Mass/volume] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29356-3","Fentanyl [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29345-6","6-Monoacetylmorphine (6-MAM) [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29337-3","Morphine Free [Mass/volume] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29294-6","Methadone [Mass/volume] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29287-0","Morphine [Presence] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29285-4","Methadone [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29278-9","Codeine [Presence] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29159-1","Methadone [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","29158-3","Opiates [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2897895,"Hydromorphone [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2888825,"Propoxyphene [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2877108,"Nalbuphine [Mass/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2862620,"Propoxyphene [Mass/volume] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2821925,"Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","28072-7","Dihydrocodeine+Hydrocodeinone [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","28061-0","Naloxone [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27920-8","Normeperidine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2753259,"Morphine [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2737920,"Sufentanil [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2737615,"Sufentanil [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27357-3","Hydrocodone Free [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27321-9","Opiates [Mass/volume] in Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27314-4","Hydromorphone Free [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27312-8","Hydrocodone Free [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27311-0","Codeine Free [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27293-0","Oxycodone Free [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27283-1","Methadone [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27281-5","Propoxyphene [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27211-2","Norpropoxyphene [Mass/mass] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27207-0","Methadone [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27206-2","Morphine Free [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27196-5","Hydromorphone Free [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27190-8","Propoxyphene [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27136-1","Opiates [Presence] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2707757,"Butorphanol [Mass/volume] in Body fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27067-8","Propoxyphene [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27064-5","Opiates [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27054-6","Morphine Free [Mass/volume] in Cerebral spinal fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27053-8","Morphine [Mass/volume] in Cerebral spinal fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27052-0","Methadone [Mass/volume] in Milk"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27041-3","Norpropoxyphene [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27035-5","Dihydrocodeine+Hydrocodeinone [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","27029-8","Norpropoxyphene [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","26869-8","Oxycodone [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","26865-6","Codeine [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","26863-1","Hydrocodone [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","26862-3","Hydromorphone [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","26860-7","Morphine [Mass/mass] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","26744-3","Opiates [Mass/mass] in Meconium by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","26722-9","Oxycodone [Mass/mass] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","26721-1","6-Monoacetylmorphine (6-MAM) [Mass/mass] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","26720-3","Codeine [Mass/mass] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","26719-5","Hydrocodone [Mass/mass] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","26718-7","Hydromorphone [Mass/mass] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","26696-5","Morphine Free [Mass/mass] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2310585,"Opiates [Presence] in Unknown substance by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2310281,"Opiates [Presence] in Unknown substance by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2310008,"Opiates [Presence] in Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2309096,"Opiates [Presence] in Urine by SAMHSA screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2308790,"Opiates [Presence] in Urine by SAMHSA confirm method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2308486,"Opiates [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2308181,"Opiates [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2307270,"Opiates [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2306964,"Opiates [Presence] in Meconium by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2306659,"Opiates [Presence] in Meconium by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2306386,"Opiates [Presence] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2305778,"Opiates [Mass/volume] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2305472,"Opiates [Presence] in Gastric fluid by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2305167,"Opiates [Presence] in Gastric fluid by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2304863,"Opiates [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",2304560,"Opiates [Mass/volume] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","21431-2","Opiates [Presence] in Urine by Screen method >2000 ng/mL"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","20551-8","Nalbuphine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","20550-0","Morphine Free [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","20540-1","Levorphanol [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","20527-8","Ethylmorphine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19650-1","Oxymorphone cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19649-3","Oxymorphone cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19648-5","Oxymorphone [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19646-9","Oxymorphone [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19645-1","Oxycodone cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19644-4","Oxycodone cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19643-6","Oxycodone [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19642-8","Oxycodone [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19637-8","Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19636-0","Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19635-2","Norpropoxyphene [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19632-9","Norpropoxyphene [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19613-9","Naltrexone cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19612-1","Naltrexone cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19611-3","Naltrexone [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19610-5","Naltrexone [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19609-7","Naltrexone [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19608-9","Nalbuphine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19607-1","Nalbuphine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19605-5","Nalbuphine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19604-8","Morphine Free cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19603-0","Morphine Free cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19602-2","Morphine Free [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19601-4","Morphine Free [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19600-6","Morphine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19599-0","Morphine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19597-4","Morphine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19593-3","6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19553-7","Methadone cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19552-9","Methadone cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19550-3","Methadone [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19535-4","Meperidine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19534-7","Meperidine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19532-1","Meperidine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19519-8","Levorphanol cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19518-0","Levorphanol cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19516-4","Levorphanol [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19488-6","Hydromorphone cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19487-8","Hydromorphone cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19486-0","Hydromorphone [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19485-2","Hydrocodone cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19484-5","Hydrocodone cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19483-7","Hydrocodone [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19482-9","Hydrocodone [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19465-4","Ethylmorphine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19464-7","Ethylmorphine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19463-9","Ethylmorphine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19462-1","Ethylmorphine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19451-4","Dihydrocodeine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19450-6","Dihydrocodeine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19449-8","Dihydrocodeine [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19448-0","Dihydrocodeine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19446-4","Dihydrocodeine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19442-3","Diamorphine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19441-5","Diamorphine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19439-9","Diamorphine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19438-1","Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19437-3","Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19436-5","Propoxyphene + Norpropoxyphene [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19435-7","Propoxyphene + Norpropoxyphene [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19434-0","Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19433-2","Propoxyphene + Norpropoxyphene [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19432-4","Propoxyphene cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19431-6","Propoxyphene cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19429-0","Propoxyphene [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19414-2","Codeine cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19413-4","Codeine cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19411-8","Codeine [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19380-5","Butorphanol cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19379-7","Butorphanol cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19378-9","Butorphanol [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19377-1","Butorphanol [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19324-3","6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19323-5","6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19322-7","6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19321-9","6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19302-9","Opiates confirm method [Identifier] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19301-1","Opiates screen method [Identifier] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19300-3","Opiates cutoff [Mass/volume] in Urine for Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19299-7","Opiates cutoff [Mass/volume] in Urine for Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19297-1","Opiates tested for in Urine by Screen method Narrative"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19296-3","Opiates tested for in Urine by Screen method Nominal"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19295-5","Opiates [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19141-1","Propoxyphene [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","19138-7","Opiates cutoff [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","18473-9","Hydromorphone [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","18435-8","Sufentanil [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","18390-5","Opiates [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","18387-1","Diamorphine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","18383-0","Alfentanil [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","18343-4","6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","18334-3","Naltrexone [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","18325-1","Oxymorphone [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","17395-5","Oxymorphone [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","17384-9","Opiates [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","17377-3","Norpropoxyphene [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","17376-5","Norpropoxyphene [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","17318-7","Nalbuphine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","17290-8","Morphine [Presence] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","17275-9","Methylfentanyl [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","17259-3","Methadone.long acting metabolite [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16998-7","Hydromorphone [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16858-3","Fentanyl [Mass/volume] in Body fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16775-9","Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16756-9","Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16755-1","Diamorphine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16754-4","Diamorphine [Mass/volume] in Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16748-6","Propoxyphene [Presence] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16747-8","Dextromoramide [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16644-7","Codeine Free [Presence] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16499-6","Butorphanol [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16334-5","Alfentanil [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16253-7","Meperidine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16252-9","Hydrocodone [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16251-1","Morphine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16250-3","Codeine [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16249-5","Oxycodone [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16248-7","6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16246-1","Methadone [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16242-0","Propoxyphene [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16218-0","Nalbuphine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16213-1","Levorphanol [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16211-5","Dihydrocodeine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16208-1","Buprenorphine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16207-3","Meperidine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16200-8","Propoxyphene [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16199-2","Methadone [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16198-4","Diamorphine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16197-6","Codeine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","16196-8","Morphine [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","15370-0","Morphine [Mass/volume] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","15364-3","Codeine [Mass/volume] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","15110-0","Morphine [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","15108-4","Methadone [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","15102-7","Codeine [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","14863-5","Oxycodone [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","14844-5","6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","14843-7","6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","14826-2","Meperidine [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","14261-2","Codeine [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","14067-3","Dihydrocodeine [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","14066-5","Dihydrocodeine [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC",1390296,"Opiates [Identifier] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","13648-1","Morphine [Presence] in Urine by SAMHSA confirm method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","13641-6","Codeine [Presence] in Urine by SAMHSA confirm method"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","13576-4","Oxycodone [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12789-4","Oxycodone Free [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12788-6","6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12787-8","Hydromorphone Free [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12786-0","Hydrocodone Free [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12785-2","Dihydrocodeine Free [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12784-5","Codeine Free [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12554-2","Narcotics and opioids [Identifier] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12550-0","Papaverine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12407-3","6-Beta naltrexone [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12395-0","Butorphanol [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12394-3","Butorphanol [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12357-0","Propoxyphene [Presence] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12356-2","Methadone [Presence] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12354-7","Opiates [Presence] in Stool"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12342-2","Oxymorphone [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12333-1","Butorphanol [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12326-5","Diamorphine [Presence] in Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12309-1","Naltrexone [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","12308-3","Hydrocodone [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","11247-4","Oxymorphone [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","11246-6","Oxycodone [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","11244-1","Morphine Free [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","11243-3","Methadone [Mass/mass] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","11235-9","Fentanyl [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","11234-2","Propoxyphene [Mass/mass] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","11075-9","Norfentanyl [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","11074-2","Norfentanyl [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","11073-4","Despropionylfentanyl [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","11072-6","Despropionylfentanyl [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","11027-0","Propoxyphene [Mass/volume] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","11025-4","Methadone [Mass/volume] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","10998-3","Oxycodone [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","10996-7","Normeperidine [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","10994-2","Naltrexone [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","10976-9","6-Monoacetylmorphine (6-MAM) [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","10975-1","6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","10544-5","Normeperidine [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","10533-8","Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","10369-7","Opiates [Mass/mass] in Hair"
"2.16.840.1.113883.6.1","LOINC","Drug abuse information sensitivity","Narcotics-Opioids-Toxicology-LOINC","10341-6","Norpropoxyphene [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP98071-1","HIV 2 p34 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP98070-3","HIV 2 p16 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP98069-5","HIV 2 gp140 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP96479-8","HIV 1+2 Ab+HIV1 p24 Ag | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP69787-7","HIV 2 p31+p34 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP64382-2","HIV Identified | Semen"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP62411-1","HIV 1+O+2 Ab"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP57525-5","HIV 2 gp120 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP57485-2","HIV 2 Ab | Cerebral spinal fluid"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP55190-0","HIV DNA | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP54308-9","HIV Identified | XXX"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP54306-3","HIV Identified | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP50859-5","HIV 2 proviral DNA | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP50555-9","HIV 2 IgG | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP48996-0","HIV 2 | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP48210-6","HIV 2 DNA | XXX"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP48209-8","HIV 2 DNA | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP47065-5","HIV 2 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP46843-6","HIV 2 p58 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP46842-8","HIV 2 p55 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP46841-0","HIV 2 p31 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP46840-2","HIV 2 gp34 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP46838-6","HIV 2 gp15 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP46836-0","HIV 2 gp105 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP42995-8","HIV 2 p41 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP41328-3","HIV 2 p68 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP41327-5","HIV 2 p56 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP41326-7","HIV 2 p53 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP41324-2","HIV 2 p26 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP41323-4","HIV 2 gp80 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP41151-9","HIV 2 gp36 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP41150-1","HIV 2 gp125 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP38465-8","HIV 2 DNA"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP38463-3","HIV 2 Ab"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP38459-1","HIV 1+2 Ab"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP38420-3","HIV identified"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP36877-6","HIV nonnucleoside reverse transcriptase gene"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP36876-8","HIV nucleoside reverse transcriptase gene"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP36650-7","HIV 1 and 2"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP32723-6","HIV reverse transcriptase+protease gene"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP30901-0","HIV protease gene"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP29063-2","HIV reverse transcriptase gene"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP16716-0","HIV 2"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP16715-2","HIV 1+2"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP14307-0","HIV 1"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP136082-7","HIV 2 RNA | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP132439-3","HIV 1 and 2 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP132221-5","HIV 1 and 2 | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","LP111605-4","HIV 2 p15 Ab | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","9836-8","HIV DNA [Presence] in Blood by Probe with amplification"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","7919-4","HIV 2 Ab [Presence] in Serum"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","69668-2","HIV 1 and 2 Ab [Identifier] in Serum or Plasma by Rapid immunoassay"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","69354-9","HIV 2 RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","69353-1","HIV 2 RNA [Presence] in Serum or Plasma by Probe and target amplification method"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","6431-1","HIV identified in Unspecified specimen by Organism specific culture"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","6430-3","HIV identified in Semen by Organism specific culture"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","6429-5","HIV identified in Blood by Organism specific culture"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","62456-9","HIV 2 p15 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","58900-2","HIV 1+2 Ab+HIV1 p24 Ag [Units/volume] in Serum by Immunoassay"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","57978-9","HIV 2 p34 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","57977-1","HIV 2 p16 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","57976-3","HIV 2 gp140 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","56888-1","HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum by Immunoassay"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","5225-8","HIV 2 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","5224-1","HIV 2 Ab [Units/volume] in Serum by Immunoassay"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","51786-2","HIV 2 Ab Signal/Cutoff in Serum by Immunoassay"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","47029-4","HIV 2 Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","45212-8","HIV 2 p31+p34 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","43185-8","HIV 1 and 2 Ab band pattern [interpretation] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","42768-2","HIV 1 and 2 Ab [interpretation] in Serum Narrative"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","34699-9","HIV 2 proviral DNA [Presence] in Serum or Plasma by Probe and target amplification method"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","33807-9","HIV 2 IgG Ab [Presence] in Serum"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","33806-1","HIV 2 IgG Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","31073-0","HIV 2 Ab band pattern [interpretation] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","30361-0","HIV 2 Ab [Presence] in Serum by Immunoassay"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","25842-6","HIV 2 DNA [Presence] in Unspecified specimen by Probe and target amplification method"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","25841-8","HIV 2 DNA [Presence] in Blood by Probe and target amplification method"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","22358-6","HIV 2 Ab [Units/volume] in Serum"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","21340-5","HIV 2 p58 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","21339-7","HIV 2 p55 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","21338-9","HIV 2 p31 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","21337-1","HIV 2 gp34 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","21336-3","HIV 2 gp15 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","21335-5","HIV 2 gp120 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","21334-8","HIV 2 gp105 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","13920-4","HIV 2 p41 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","11082-5","HIV 2 p68 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","11081-7","HIV 2 p56 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","11080-9","HIV 2 p53 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","11079-1","HIV 2 p26 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","11078-3","HIV 2 gp80 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","10902-5","HIV 2 gp36 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","HIV/AIDS information sensitivity","HIV-Related-Tests-LOINC","10901-7","HIV 2 gp125 Ab [Presence] in Serum by Immunoblot (IB)"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP54131-5","Ethanol | Exhaled gas"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP53374-2","Ethyl glucuronide | Urine"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP51222-5","Disulfiram | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP50880-1","Ethanol | Saliva"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP49842-5","Ethanol | XXX"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP47217-2","Ethanol | Urine"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP45002-0","Ethanol | Body Fluid"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP45001-2","Ethanol | Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP44964-2","Disulfiram | Urine"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP44049-2","Ethanol | Meconium"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP43273-9","Ethanol | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP42011-4","Ethanol | Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP40656-8","Ethanol | Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP172697-7","Ethanol+Methanol+Isopropyl alchohol+Acetone | Bld-Ser-Plas"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP16119-7","Disulfiram"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP14348-4","Ethanol"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","LP131065-7","Ethanol | Tissue and Smears"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","9357-5","Disulfiram [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","61095-6","Ethanol [Presence] in Gastric fluid by Screen method"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","61066-7","Ethanol [Presence] in Unspecified specimen by Screen method"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","58378-1","Ethyl glucuronide [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","58377-3","Ethyl glucuronide [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","58376-5","Ethyl glucuronide/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","58375-7","Ethyl glucuronide [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","58356-7","Ethanol/Creatinine [Mass Ratio] in Urine"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","56478-1","Ethanol [Mass/volume] in Blood by Gas chromatography"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","5645-7","Ethanol [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","5644-0","Ethanol [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","5643-2","Ethanol [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","5642-4","Ethanol [Presence] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","5641-6","Ethanol [Mass/volume] in Exhaled gas"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","5640-8","Ethanol [Mass/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","5639-0","Ethanol [Presence] in Blood"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","55349-5","Ethyl glucuronide [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","50343-3","Ethanol [Presence] in Saliva (oral fluid) by Screen method"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","50022-3","Ethanol+Methanol+Isopropyl alchohol+Acetone [Presence] in Serum, Plasma or Blood"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","48342-0","Ethanol+Methanol+Isopropyl alchohol+Acetone [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","47107-8","Ethanol [Moles/volume] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","46983-3","Ethanol [Mass/volume] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","45324-1","Ethyl glucuronide [Mass/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","42242-8","Ethanol [Presence] in Urine by Screen method"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","40530-8","Ethanol [Presence] in Gastric fluid"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","3577-4","Disulfiram [Mass/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","35664-2","Ethanol [Mass/volume] in unspecified time Urine"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","34882-1","Ethanol [Mass/volume] in Saliva (oral fluid)"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","34180-0","Ethanol [Presence] in Urine by Confirmatory method"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","32070-5","Ethanol [Moles/volume] in Unspecified specimen"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","23861-8","Ethanol [Mass/mass] in Tissue"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","22745-4","Ethanol [Moles/volume] in Urine"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","20470-1","Ethanol [Presence] in Serum or Plasma by Screen method"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","16843-5","Ethanol [Mass/volume] in Body fluid"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","16842-7","Ethanol [Mass/volume] in Unknown substance"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","16781-7","Disulfiram [Presence] in Urine"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","15402-1","Ethanol [Presence] in Meconium"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","15120-9","Ethanol [Moles/volume] in Blood"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","14719-9","Ethanol [Moles/volume] in Serum or Plasma"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","14336-2","Ethanol [Mass/volume] in Serum or Plasma by Gas chromatography"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","12465-1","Ethanol [Mass/volume] in Vitreous fluid"
"2.16.840.1.113883.6.1","LOINC","Alcohol Abuse and Alcoholism Information","Alcohol-Ethanol-Toxicology-LOINC","10367-1","Ethanol [Mass/volume] in Gastric fluid"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",991149,"Methadose 0.333 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",991147,"Methadone Hydrochloride 0.333 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",967897,"Campral Dose Pak"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",967896,"{180 (Acamprosate calcium 333 MG Enteric Coated Tablet) } Pack"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",904882,"BuTrans 5 MCG/HR Weekly Transdermal Patch"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",904880,"168 HR Buprenorphine 0.005 MG/HR Transdermal Patch"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",904878,"BuTrans 20 MCG/HR Weekly Transdermal Patch"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",904876,"168 HR Buprenorphine 0.02 MG/HR Transdermal Patch"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",904874,"BuTrans 10 MCG/HR Weekly Transdermal Patch"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",904871,"BuTrans"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",904870,"168 HR Buprenorphine 0.01 MG/HR Transdermal Patch"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",866331,"Morphine / Naltrexone"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",864980,"Methadose 0.333 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",864978,"Methadone Hydrochloride 0.333 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",864769,"Methadone Hydrochloride 2 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",864761,"Methadone Hydrochloride 1 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",864737,"Methadose 5 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",864720,"Dolophine 5 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",864718,"Methadone Hydrochloride 5 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",864714,"Methadone Hydrochloride 10 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",864712,"Methadose 10 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",864708,"Dolophine 10 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",864706,"Methadone Hydrochloride 10 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",863857,"MS 80 MG / Naltrexone hydrochloride 3.2 MG Extended Release Capsule [Embeda]"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",863856,"Morphine Sulfate 80 MG / Naltrexone hydrochloride 3.2 MG Extended Release Capsule"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",863855,"MS 60 MG / Naltrexone hydrochloride 2.4 MG Extended Release Capsule [Embeda]"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",863854,"Morphine Sulfate 60 MG / Naltrexone hydrochloride 2.4 MG Extended Release Capsule"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",863853,"MS 50 MG / Naltrexone hydrochloride 2 MG Extended Release Capsule [Embeda]"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",863852,"Morphine Sulfate 50 MG / Naltrexone hydrochloride 2 MG Extended Release Capsule"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",863851,"MS 30 MG / Naltrexone hydrochloride 1.2 MG Extended Release Capsule [Embeda]"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",863850,"Morphine Sulfate 30 MG / Naltrexone hydrochloride 1.2 MG Extended Release Capsule"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",863849,"MS 20 MG / Naltrexone hydrochloride 0.8 MG Extended Release Capsule [Embeda]"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",863848,"Morphine Sulfate 20 MG / Naltrexone hydrochloride 0.8 MG Extended Release Capsule"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",863847,"MS 100 MG / Naltrexone hydrochloride 4 MG Extended Release Capsule [Embeda]"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",863845,"Morphine Sulfate 100 MG / Naltrexone hydrochloride 4 MG Extended Release Capsule"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",859959,"Embeda"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",835728,"Campral 333 MG (equivalent to acamprosate 300 MG) Enteric Coated Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",835726,"Acamprosate calcium 333 MG Enteric Coated Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",82819,"acamprosate"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",7243,"Naltrexone"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",6813,"Methadone"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",637216,"Vivitrol 112 MG/ML Injectable Suspension"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",637213,"Naltrexone 112 MG/ML Injectable Suspension"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",636556,"Vivitrol"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",602959,"Campral"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",542214,"Depade 50 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",542207,"Depade"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",404414,"Subutex 8 MG Sublingual Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",404413,"Subutex 2 MG Sublingual Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",3554,"Disulfiram"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",352990,"Suboxone"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",352364,"Buprenorphine / Naloxone"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",351267,"Buprenorphine 8 MG / Naloxone 2 MG Sublingual Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",351266,"Buprenorphine 2 MG / Naloxone 0.5 MG Sublingual Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",351265,"Buprenorphine 8 MG Sublingual Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",351264,"Buprenorphine 2 MG Sublingual Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",250426,"buprenorphine (as buprenorphine hydrochloride) 0.4 MG Sublingual Tablet [250426]"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",246474,"Buprenorphine 0.2 MG Sublingual Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",238129,"Buprenorphine 0.3 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",210716,"Antabuse 500 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",210628,"Antabuse 250 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",207028,"ReVia 50 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",205533,"Buprenex 0.3 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",203840,"Buprenex"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",202370,"Dolophine"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",199731,"Disulfiram 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",198011,"Naltrexone 50 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",197624,"Disulfiram 500 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",197623,"Disulfiram 250 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1819,"Buprenorphine"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1818,"Subutex"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",152751,"Methadose"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",152092,"ReVia"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1432971,"BuTrans 15 MCG/HR Weekly Transdermal Patch"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1432969,"168 HR Buprenorphine 0.015 MG/HR Transdermal Patch"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1431104,"Zubsolv 5.7/1.4 Sublingual Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1431102,"Buprenorphine 5.7 MG / Naloxone 1.4 MG Sublingual Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1431083,"Zubsolv 1.4/0.36 Sublingual Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1431077,"Zubsolv"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1431076,"Buprenorphine 1.4 MG / Naloxone 0.36 MG Sublingual Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1361710,"1 ML Methadone Hydrochloride 1 MG/ML Prefilled Syringe"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1307063,"Suboxone 12/3 Sublingual Film"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1307061,"Buprenorphine 12 MG / Naloxone 3 MG Oral Strip"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1307058,"Suboxone 4/1 Sublingual Film"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1307056,"Buprenorphine 4 MG / Naloxone 1 MG Oral Strip"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",105069,"Naltrexone hydrochloride"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1010609,"Suboxone 8/2 Sublingual Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1010608,"Suboxone 2/0.5 Sublingual Tablet"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1010606,"Suboxone 8/2 Sublingual Film"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1010604,"Buprenorphine 8 MG / Naloxone 2 MG Oral Strip"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1010603,"Suboxone 2/0.5 Sublingual Film"
"2.16.840.1.113883.6.88","RxNorm","Drug abuse information sensitivity","Substance-Abuse-Treatment-RxNorm",1010600,"Buprenorphine 2 MG / Naloxone 0.5 MG Oral Strip"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",998426,"Xerese (acyclovir 5 % / hydrocortisone 1 % ) Topical Cream"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",998425,"Acyclovir / Hydrocortisone Topical Cream [Xerese]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",998424,"Acyclovir 50 MG/ML / Hydrocortisone 10 MG/ML [Xerese]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",998423,"Xerese"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",998422,"Acyclovir 50 MG/ML / Hydrocortisone 10 MG/ML Topical Cream"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",998421,"Acyclovir / Hydrocortisone Topical Cream"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",992413,"Itraconazole 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",992412,"Itraconazole 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",991219,"Gammaplex 5 % Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",991218,"Immunoglobulin G Injectable Solution [Gammaplex]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",991217,"Immunoglobulin G, Human 50 MG/ML [Gammaplex]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",991216,"Gammaplex"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",970789,"Buccal Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",9384,"Rifampin"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",92776,"Gammar"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",92432,"Fluconazole Injectable Solution [Diflucan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",902753,"Hizentra 20 % Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",902752,"Immunoglobulin G Injectable Solution [Hizentra]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",902751,"Immunoglobulin G, Human 200 MG/ML [Hizentra]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",902750,"Hizentra"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",902749,"Immunoglobulin G, Human 200 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",902748,"Immunoglobulin G, Human 200 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",900577,"Norvir 100 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",900576,"Ritonavir Oral Tablet [Norvir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",900575,"Ritonavir 100 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",900574,"Ritonavir Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",876429,"SMX 40 MG/ML / TMP 8 MG/ML Oral Suspension [Septra]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",876428,"Sulfamethoxazole / Trimethoprim Oral Suspension [Septra]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",876427,"Sulfamethoxazole 40 MG/ML / Trimethoprim 8 MG/ML [Septra]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",876409,"Gammar-P I.V. 50 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",876408,"Immunoglobulin G Injectable Solution [Gammar]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",876407,"Immunoglobulin G, Human 50 MG/ML [Gammar]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",864661,"efavirenz 600 MG / lamiVUDine 300 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",864660,"efavirenz / lamiVUDine / tenofovir disoproxil Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",864650,"Zirgan 0.15 % Ophthalmic Gel"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",864649,"Ganciclovir Ophthalmic Gel [Zirgan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",864648,"Ganciclovir 0.0015 MG/MG [Zirgan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",864647,"Zirgan"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",863562,"Valcyte 50 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",863561,"valGANciclovir Oral Solution [Valcyte]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",863560,"valGANciclovir 50 MG/ML [Valcyte]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",863559,"valGANciclovir 50 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",863558,"valGANciclovir Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",863557,"valGANciclovir 50 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",861032,"Viracept 0.05 MG/MG Oral Powder"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",861031,"Nelfinavir Oral Powder [Viracept]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",861030,"Nelfinavir 0.05 MG/MG [Viracept]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",859865,"Invirase 500 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",859864,"saquinavir mesylate 500 MG [Invirase]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",859863,"saquinavir mesylate 500 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",859862,"saquinavir mesylate 500 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",859861,"Invirase 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",859860,"saquinavir mesylate 200 MG [Invirase]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",859859,"saquinavir mesylate 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",859858,"saquinavir mesylate 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",859857,"saquinavir mesylate"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",85762,"Ritonavir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",856612,"Rescriptor 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",856611,"Delavirdine Mesylate 200 MG [Rescriptor]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",856610,"Delavirdine Mesylate 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",856609,"Delavirdine Mesylate 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",856562,"Rescriptor 100 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",856561,"Delavirdine Mesylate 100 MG [Rescriptor]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",856560,"Delavirdine Mesylate 100 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",856559,"Delavirdine Mesylate 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",850457,"Prezista 150 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",850456,"darunavir 150 MG [Prezista]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",850455,"darunavir 150 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",850454,"darunavir 150 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",849580,"Bactrim DS 800 MG / 160 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",849579,"Sulfamethoxazole 800 MG / Trimethoprim 160 MG [Bactrim]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",847749,"Kaletra Solution 80/20 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",847748,"lopinavir / Ritonavir Oral Solution [Kaletra]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",847747,"lopinavir 80 MG/ML / Ritonavir 20 MG/ML [Kaletra]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",847745,"Kaletra 100 MG / 25 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",847743,"lopinavir 100 MG / Ritonavir 25 MG [Kaletra]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",847741,"Kaletra 200 MG / 50 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",847740,"lopinavir / Ritonavir Oral Tablet [Kaletra]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",847739,"lopinavir 200 MG / Ritonavir 50 MG [Kaletra]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",83816,"Delavirdine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",83395,"Saquinavir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",833173,"Sporanox PulsePak"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",833172,"{28 (Itraconazole 100 MG Oral Capsule) } Pack"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",833164,"Sporanox 100 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",833163,"Itraconazole Oral Capsule [Sporanox]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",833162,"Itraconazole 100 MG [Sporanox]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",831870,"Prezista 75 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",831869,"darunavir 75 MG [Prezista]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",831868,"darunavir 75 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",831867,"darunavir 75 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",83171,"Cidofovir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",83170,"Vistide"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",825321,"Zovirax 5 % Topical Cream"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",824876,"Prezista 400 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",824875,"darunavir 400 MG [Prezista]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",824338,"darunavir 400 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",824337,"darunavir 400 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",824002,"Septra DS 800/160 Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",824001,"Sulfamethoxazole / Trimethoprim Oral Tablet [Septra]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",824000,"Sulfamethoxazole 800 MG / Trimethoprim 160 MG [Septra]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",805515,"Aptivus 100 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",805514,"tipranavir Oral Solution [Aptivus]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",805513,"tipranavir 100 MG/ML [Aptivus]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",802321,"tipranavir 100 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",802320,"tipranavir Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",802319,"tipranavir 100 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",797557,"GamaSTAN 180 UNT/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",797556,"Immunoglobulin G Injectable Solution [GamaSTAN]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",797555,"Immunoglobulin G, Human 180 UNT/ML [GamaSTAN]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",797554,"GamaSTAN"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",797553,"Immunoglobulin G, Human 180 UNT/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",797551,"Immunoglobulin G, Human 180 UNT/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",794610,"Prezista 600 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",794609,"darunavir 600 MG [Prezista]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",76162,"Rifater"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",758999,"Privigen 10 % Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",758998,"Immunoglobulin G Injectable Solution [Privigen]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",758997,"Immunoglobulin G, Human 100 MG/ML [Privigen]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",758996,"Privigen"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",758555,"Intelence 100 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",758554,"etravirine Oral Tablet [Intelence]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",758553,"etravirine 100 MG [Intelence]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",758552,"Intelence"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",757692,"Nevirapine 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",756806,"Zidovudine Oral Solution [Retrovir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",756805,"Zidovudine Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",756209,"Zidovudine 10 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",755298,"Retrovir 10 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",754761,"etravirine 100 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",754760,"etravirine Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",754759,"etravirine 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",746645,"lopinavir 100 MG / Ritonavir 25 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",746644,"Ritonavir 25 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",746643,"lopinavir 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",744846,"ISENTRESS 400 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",744845,"raltegravir Oral Tablet [ISENTRESS]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",744844,"raltegravir 400 MG [ISENTRESS]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",744843,"ISENTRESS"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",744842,"raltegravir 400 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",744841,"raltegravir Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",744840,"raltegravir 400 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",732,"Amphotericin B"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",723827,"Lexiva 50 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",723826,"fosamprenavir Oral Suspension [Lexiva]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",723825,"fosamprenavir 50 MG/ML [Lexiva]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",719872,"raltegravir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",706237,"Didanosine Enteric Coated Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",706046,"Didanosine Enteric Coated Capsule [Videx EC]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",706045,"Didanosine Enteric Coated Capsule [Videx]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",706018,"Delavirdine Oral Tablet [Rescriptor]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",70223,"Aldesleukin"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",701858,"Aczone 5 % Topical Gel"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",701857,"Dapsone Topical Gel [Aczone]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",701856,"Dapsone 0.05 MG/MG [Aczone]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",692960,"Amphotericin B / Tetracycline"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",690741,"sulfADIAZINE / Sulfamerazine / Sulfamethazine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",68244,"lamiVUDine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",670026,"darunavir 600 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",670025,"darunavir 600 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",664743,"Reyataz 300 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",664742,"Atazanavir 300 MG [Reyataz]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",664741,"Atazanavir 300 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",664740,"Atazanavir 300 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",646830,"DAUNOrubicin Liposomal 2 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",646829,"DAUNOrubicin Liposomal Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",646828,"DAUNOrubicin Liposomal 2 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",643077,"darunavir Oral Tablet [Prezista]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",643075,"Prezista"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",643074,"darunavir 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",643073,"darunavir Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",643072,"darunavir 300 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",643070,"Atripla 600/200/300 Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",643069,"efavirenz / emtricitabine / tenofovir disoproxil Oral Tablet [Atripla]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",643068,"efavirenz 600 MG / emtricitabine 200 MG / Tenofovir disoproxil fumarate 300 MG [Atripla]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",643067,"Atripla"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",643066,"efavirenz 600 MG / emtricitabine 200 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",643065,"efavirenz / emtricitabine / tenofovir disoproxil Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",639888,"Truvada (emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (tenofovir disoproxil 245 MG) ) Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",639887,"emtricitabine 200 MG / Tenofovir disoproxil fumarate 300 MG [Truvada]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",632427,"tenofovir disoproxil Oral Tablet [Viread]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",632025,"tenofovir disoproxil Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",631357,"INH 150 MG / Rifampin 300 MG Oral Capsule [IsonaRif]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",631356,"isoniazid / Rifampin Oral Capsule [IsonaRif]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",631355,"isoniazid 150 MG / Rifampin 300 MG [IsonaRif]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",631354,"IsonaRif"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",617621,"Vivaglobin 16 % Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",617620,"Immunoglobulin G Injectable Solution [Vivaglobin]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",617619,"Immunoglobulin G, Human 160 MG/ML [Vivaglobin]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",616633,"Vivaglobin"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",616148,"Emtriva 10 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",616147,"emtricitabine Oral Solution [Emtriva]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",616146,"emtricitabine 10 MG/ML [Emtriva]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",614593,"Aptivus"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",614534,"abacavir / Lamivudine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",607295,"Dapsone 0.05 MG/MG Topical Gel"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",607294,"Dapsone Topical Gel"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",607293,"Dapsone 0.05 MG/MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",607273,"Vitrasert 4.5 MG Drug Implant"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",607272,"Ganciclovir Drug Implant [Vitrasert]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",607271,"Ganciclovir 4.5 MG [Vitrasert]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",606479,"Gammagard 100 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",606478,"Immunoglobulin G Injectable Solution [Gammagard]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",606477,"Immunoglobulin G, Human 100 MG/ML [Gammagard]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",605173,"Aczone"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",604020,"Ganciclovir 4.5 MG Drug Implant"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",604019,"Ganciclovir Drug Implant"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",604018,"Ganciclovir 4.5 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",603378,"Aptivus 250 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",603377,"tipranavir Oral Capsule [Aptivus]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",603376,"tipranavir 250 MG [Aptivus]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",602395,"abacavir 600 MG / Lamivudine 300 MG Oral Tablet [Epzicom]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",602394,"abacavir 600 MG / Lamivudine 300 MG [Epzicom]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",602393,"abacavir 600 MG / Lamivudine 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",602392,"abacavir 600 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",597730,"lopinavir 200 MG / Ritonavir 50 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",597729,"lopinavir / Ritonavir Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",597728,"Ritonavir 50 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",597727,"lopinavir 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",59763,"Stavudine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",597291,"emtricitabine 10 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",597290,"emtricitabine Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",597289,"emtricitabine 10 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",597267,"fosamprenavir 50 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",597266,"fosamprenavir Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",597265,"fosamprenavir 50 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",591533,"sulfADIAZINE / Trimethoprim"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",577212,"tipranavir 250 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",577211,"tipranavir Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",577210,"tipranavir 250 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",576513,"emtricitabine 200 MG [Emtriva]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",576416,"enfuvirtide 90 MG/ML [Fuzeon]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",576110,"fosamprenavir 700 MG [Lexiva]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",576103,"Atazanavir 100 MG [Reyataz]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",576102,"Atazanavir 150 MG [Reyataz]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",576101,"Atazanavir 200 MG [Reyataz]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",575950,"lamiVUDine 300 MG [Epivir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",575878,"efavirenz 600 MG [Sustiva]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",575802,"Tenofovir disoproxil fumarate 300 MG [Viread]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",575271,"Immunoglobulin G, Human 120 MG/ML [Carimune]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",575077,"abacavir 300 MG / Lamivudine 150 MG / Zidovudine 300 MG [Trizivir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",575014,"valGANciclovir 450 MG [Valcyte]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",574929,"Didanosine 125 MG [Videx]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",574572,"Trimethoprim 10 MG/ML [Primsol]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",573579,"Acyclovir 50 MG/ML [Zovirax]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",573569,"Acyclovir 800 MG [Zovirax]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",573372,"lamiVUDine 5 MG/ML [Epivir HBV]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",573371,"lamiVUDine 100 MG [Epivir HBV]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",573349,"abacavir 20 MG/ML [Ziagen]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",573348,"abacavir 300 MG [Ziagen]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",573298,"Nevirapine 10 MG/ML [Viramune]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",573286,"efavirenz 50 MG [Sustiva]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",573284,"efavirenz 200 MG [Sustiva]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",573017,"lamiVUDine 150 MG / Zidovudine 300 MG [Combivir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",572422,"Nelfinavir 250 MG [Viracept]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",571769,"Nevirapine 200 MG [Viramune]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",571699,"Cidofovir 75 MG/ML [Vistide]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",570534,"Acyclovir 0.05 MG/MG [Zovirax]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",569301,"Trimethoprim 100 MG [Trimpex]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",569148,"Polymyxin B 10000 UNT/ML / Trimethoprim 1 MG/ML [Polytrim]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",569113,"Sulfamethoxazole 400 MG / Trimethoprim 80 MG [Bactrim]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",569104,"Sulfamethoxazole 40 MG/ML / Trimethoprim 8 MG/ML [Sulfatrim]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",568199,"Rifampin 60 MG/ML [Rifadin IV]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",567918,"Flucytosine 500 MG [Ancobon]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",567916,"Flucytosine 250 MG [Ancobon]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",567900,"Fluconazole 100 MG [Diflucan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",567515,"isoniazid 150 MG / Rifampin 300 MG [Rifamate]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",567511,"isoniazid 50 MG / Pyrazinamide 300 MG / Rifampin 120 MG [Rifater]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566742,"Immunoglobulin G, Human 100 MG/ML [Polygam S/D]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566738,"Immunoglobulin G, Human 50 MG/ML [Iveegam]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566736,"Immunoglobulin G, Human 100 MG/ML [Venoglobulin-S 10%]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566631,"Ganciclovir 50 MG/ML [Cytovene]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",5666,"Immunoglobulin G"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566054,"Pyrimethamine 25 MG [Daraprim]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566052,"Zidovudine 100 MG [Retrovir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566051,"Acyclovir 400 MG [Zovirax]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566049,"Acyclovir 40 MG/ML [Zovirax]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566048,"Acyclovir 200 MG [Zovirax]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566047,"Fluconazole 40 MG/ML [Diflucan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566046,"Fluconazole 10 MG/ML [Diflucan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566045,"Fluconazole 2 MG/ML [Diflucan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566044,"Fluconazole 200 MG [Diflucan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",566037,"Rifampin 150 MG [Rifadin]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",565345,"Stavudine 1 MG/ML [Zerit]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",565300,"Immunoglobulin G, Human 50 MG/ML [Octagam]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",565179,"Indinavir 400 MG [Crixivan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",565178,"Indinavir 200 MG [Crixivan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",565135,"Ritonavir 80 MG/ML [Norvir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",565134,"Ritonavir 100 MG [Norvir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",565120,"Stavudine 40 MG [Zerit]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",565119,"Stavudine 30 MG [Zerit]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",565118,"Stavudine 20 MG [Zerit]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",565117,"Stavudine 15 MG [Zerit]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",565112,"lamiVUDine 10 MG/ML [Epivir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",565111,"lamiVUDine 150 MG [Epivir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",565059,"Zidovudine 300 MG [Retrovir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",564526,"Zidovudine 10 MG/ML [Retrovir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",564144,"Aldesleukin 1.1 MG/ML [Proleukin]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",564028,"Fluconazole 150 MG [Diflucan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",564027,"Fluconazole 50 MG [Diflucan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",564013,"Rifampin 300 MG [Rimactane]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",563142,"Rifampin 300 MG [Rifadin]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",562707,"Trimethoprim 10 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",547199,"Baygam 150 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",547198,"Immunoglobulin G Injectable Solution [Baygam]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",547197,"Immunoglobulin G, Human 150 MG/ML [Baygam]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",547196,"Immunoglobulin G, Human 150 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",547195,"Immunoglobulin G, Human 150 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",545188,"Sporanox 10 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",545187,"Itraconazole Injectable Solution [Sporanox]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",545186,"Itraconazole 10 MG/ML [Sporanox]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",545184,"Gamunex-C 10 % Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",545183,"Immunoglobulin G Injectable Solution [Gamunex]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",545182,"Immunoglobulin G, Human 100 MG/ML [Gamunex]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",545179,"Gammagard S/D 50 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",545178,"Immunoglobulin G, Human 50 MG/ML [Gammagard S/D]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",542370,"Viracept 625 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",542369,"Nelfinavir 625 MG [Viracept]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",542059,"Videx 20 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",542058,"Didanosine 20 MG/ML [Videx]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",541558,"Flebogamma 5 % Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",541557,"Immunoglobulin G Injectable Solution [Flebogamma]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",541556,"Immunoglobulin G, Human 50 MG/ML [Flebogamma]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",541555,"Flebogamma"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",541058,"Crixivan 100 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",541057,"Indinavir 100 MG [Crixivan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",540398,"emtricitabine / tenofovir disoproxil Oral Tablet [Truvada]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",540395,"emtricitabine / tenofovir disoproxil Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",539824,"abacavir / Lamivudine Oral Tablet [Epzicom]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",539804,"Saquinavir Oral Tablet [Invirase]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",539698,"Didanosine 400 MG [Videx EC]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",539691,"Didanosine 250 MG [Videx EC]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",539688,"Didanosine 200 MG [Videx EC]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",53654,"Nevirapine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",497184,"Epzicom"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",495430,"Truvada"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",485467,"Saquinavir Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",476556,"emtricitabine 200 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",476143,"abacavir / Lamivudine Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",475969,"etravirine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",471329,"Gamunex"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",4678,"Ganciclovir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",460132,"darunavir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",451785,"sulfADIAZINE 410 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",451782,"sulfADIAZINE / Trimethoprim Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",4451,"Flucytosine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",4450,"Fluconazole"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",440925,"Itraconazole Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",437347,"Acyclovir 2 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",42750,"Iveegam"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",42697,"Gammagard"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",419921,"Didanosine 20 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",415660,"Acyclovir 2 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",406217,"Stavudine 75 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",406216,"Stavudine 50 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",406215,"Stavudine 37.5 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",406214,"Stavudine Extended Release Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",406213,"Stavudine 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",406115,"Nelfinavir 625 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",406055,"enfuvirtide Injectable Solution [Fuzeon]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",406018,"emtricitabine Oral Capsule [Emtriva]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",406017,"emtricitabine Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",406016,"emtricitabine 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",404587,"Emtriva 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",404460,"Fuzeon 90 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",403978,"Nelfinavir 625 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",403875,"emtricitabine 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",403817,"Stavudine 100 MG Extended Release Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",403816,"Stavudine 75 MG Extended Release Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",403815,"Stavudine 50 MG Extended Release Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",403814,"Stavudine 37.5 MG Extended Release Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",403145,"Fluconazole Oral Suspension [Diflucan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",403126,"Acyclovir Topical Cream [Zovirax]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402626,"Trimethoprim 20 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402415,"enfuvirtide Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402414,"enfuvirtide 90 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402370,"Atazanavir Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402367,"fosamprenavir Oral Tablet [Lexiva]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402366,"fosamprenavir Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402364,"fosamprenavir 700 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402335,"Atazanavir 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402334,"Atazanavir 150 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402333,"Atazanavir Oral Capsule [Reyataz]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402332,"Atazanavir 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402247,"Atazanavir 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402246,"Atazanavir 150 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402245,"Atazanavir 100 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402110,"Lexiva 700 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402109,"fosamprenavir 700 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402108,"Lexiva"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402095,"Reyataz 100 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402094,"Reyataz 150 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",402093,"Reyataz 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",401981,"enfuvirtide 90 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",393562,"Stavudine Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",393334,"Tenofovir disoproxil fumarate 300 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",393324,"Ganciclovir Ophthalmic Gel"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",393323,"Ganciclovir 0.0015 MG/MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",392458,"Dapsone / Pyrimethamine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",388052,"Ganciclovir 0.0015 MG/MG Ophthalmic Gel"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",386065,"Immunoglobulin G Injectable Solution [Octagam]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",385979,"Itraconazole Oral Solution [Sporanox]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",385496,"Immunoglobulin G, Human 160 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",384480,"Didanosine 1.67 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",384478,"Didanosine 2.5 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",384477,"Didanosine 1 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",383858,"Emtriva"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",382467,"Reyataz"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",379128,"Polymyxin B / Trimethoprim Ophthalmic Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",379127,"Zalcitabine Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",379126,"Zidovudine Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",378973,"Amphotericin B Topical Cream"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",378707,"Indinavir Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",378651,"Itraconazole Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",378299,"efavirenz Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",378235,"Nelfinavir Oral Powder"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",377580,"Amphotericin B Topical Lotion"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",377568,"Acyclovir Topical Cream"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",377223,"Itraconazole Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",377143,"Acyclovir Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",377136,"Cidofovir Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",377117,"Sulfamethoxazole / Trimethoprim Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",377114,"Rifampin Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",377091,"Aldesleukin Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",377071,"Fluconazole Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",376663,"Ganciclovir Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",376660,"Amphotericin B Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",376640,"sulfADIAZINE / Sulfamerazine / Sulfamethazine Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",376438,"Amphotericin B Topical Ointment"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",375982,"Trimethoprim Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",375802,"Didanosine Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",375072,"Flucytosine Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",374813,"abacavir / Lamivudine / Zidovudine Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",374656,"valGANciclovir Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",374643,"lopinavir / Ritonavir Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",374642,"lopinavir / Ritonavir Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",374595,"Nevirapine Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",374473,"Acyclovir Topical Ointment"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",374332,"Zidovudine Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",374331,"Zidovudine Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",374234,"Sulfamethoxazole / Trimethoprim Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",374233,"Sulfamethoxazole / Trimethoprim Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",374230,"Trimethoprim Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",374229,"Trimethoprim Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",374059,"Amphotericin B / Tetracycline Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",373979,"Pyrimethamine / Sulfadoxine Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",373977,"sulfADIAZINE Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",373959,"Stavudine Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",373825,"Saquinavir Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",373796,"Ritonavir Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",373795,"Ritonavir Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",373783,"Rifampin Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",373781,"Rifampin Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",373718,"Pyrimethamine Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",373046,"Nevirapine Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",373015,"Nelfinavir Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",372564,"lamiVUDine / Zidovudine Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",372563,"lamiVUDine Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",372562,"lamiVUDine Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",372509,"isoniazid / Rifampin Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",372508,"isoniazid / Rifampin Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",372292,"Ganciclovir Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",372212,"Flucytosine Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",372211,"Flucytosine Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",372210,"Fluconazole Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",372209,"Fluconazole Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",372208,"Fluconazole Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",372003,"efavirenz Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",371819,"Didanosine Chewable Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",371699,"Delavirdine Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",371690,"Dapsone / Pyrimethamine Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",371689,"Dapsone Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",370912,"Amprenavir Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",370911,"Amprenavir Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",370782,"Acyclovir Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",370725,"Itraconazole Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",370684,"Indinavir Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",370583,"Amphotericin B Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",370537,"Acyclovir Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",370536,"Acyclovir Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",370503,"abacavir Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",370502,"abacavir Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",369334,"Pyrimethamine Oral Tablet [Daraprim]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",369244,"Sulfamethoxazole / Trimethoprim Oral Tablet [Bactrim]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",369227,"Trimethoprim Oral Tablet [Trimpex]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",368877,"isoniazid / Pyrazinamide / Rifampin Oral Tablet [Rifater]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",368780,"Fluconazole Oral Tablet [Diflucan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",368582,"efavirenz Oral Tablet [Sustiva]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",368418,"Nelfinavir Oral Tablet [Viracept]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",368309,"lamiVUDine / Zidovudine Oral Tablet [Combivir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",368253,"abacavir Oral Tablet [Ziagen]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",368247,"lamiVUDine Oral Tablet [Epivir HBV]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",368174,"Acyclovir Oral Tablet [Zovirax]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",368153,"abacavir / Lamivudine / Zidovudine Oral Tablet [Trizivir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",368141,"valGANciclovir Oral Tablet [Valcyte]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",367794,"lamiVUDine Oral Tablet [Epivir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",367746,"Nevirapine Oral Tablet [Viramune]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",367700,"Zidovudine Oral Tablet [Retrovir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",367387,"Acyclovir Topical Ointment [Zovirax]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",366740,"isoniazid / Rifampin Oral Capsule [Rifamate]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",366732,"Rifampin Oral Capsule [Rifadin]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",366731,"Rifampin Oral Capsule [Rimactane]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",366708,"Stavudine Oral Capsule [Zerit]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",366687,"Zidovudine Oral Capsule [Retrovir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",366550,"Acyclovir Oral Capsule [Zovirax]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",366448,"efavirenz Oral Capsule [Sustiva]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",366441,"Indinavir Oral Capsule [Crixivan]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",366398,"Ritonavir Oral Capsule [Norvir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",366292,"Saquinavir Oral Capsule [Invirase]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",366217,"Flucytosine Oral Capsule [Ancobon]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",366081,"Nevirapine Oral Suspension [Viramune]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",366069,"Acyclovir Oral Suspension [Zovirax]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",364697,"lamiVUDine Oral Solution [Epivir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",364692,"Ritonavir Oral Solution [Norvir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",364596,"abacavir Oral Solution [Ziagen]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",364593,"lamiVUDine Oral Solution [Epivir HBV]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",364584,"Didanosine Oral Solution [Videx]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",364572,"Trimethoprim Oral Solution [Primsol]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",364319,"Stavudine Oral Solution [Zerit]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",363461,"Immunoglobulin G Injectable Solution [Venoglobulin-S 10%]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",363453,"Rifampin Injectable Solution [Rifadin IV]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",362931,"Cidofovir Injectable Solution [Vistide]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",362878,"Zidovudine Injectable Solution [Retrovir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",362823,"Ganciclovir Injectable Solution [Cytovene]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",362781,"Immunoglobulin G Injectable Solution [Carimune]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",362693,"Immunoglobulin G Injectable Solution [Polygam S/D]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",362673,"Aldesleukin Injectable Solution [Proleukin]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",362579,"Immunoglobulin G Injectable Solution [Gammagard S/D]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",362567,"Immunoglobulin G Injectable Solution [Iveegam]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",358418,"Amphotericin B 30 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",358262,"fosamprenavir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",356743,"Fuzeon"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",353492,"Immunoglobulin G, Human 0.2 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",352504,"Carimune"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",352230,"Epivir 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",352143,"Sustiva 600 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",352050,"Viread 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",351326,"Carimune 12 % Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",351129,"Immunoglobulin G, Human 0.2 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",351086,"Indinavir 400 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",350655,"lamiVUDine 300 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",350652,"efavirenz 600 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",349491,"lamiVUDine 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",349477,"efavirenz 600 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",349251,"Tenofovir disoproxil fumarate 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",348506,"Itraconazole 10 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",346473,"Immunoglobulin G, Human 50 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",343818,"Immunoglobulin G, Human 100 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",343815,"Immunoglobulin G, Human 120 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",343725,"Acyclovir 50 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",343047,"Atazanavir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",34246,"Polymyxin B / Trimethoprim Ophthalmic Solution [Polytrim]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",340674,"sulfADIAZINE 33.4 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",340137,"Nelfinavir 0.05 MG/MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",340089,"Acyclovir 0.05 MG/MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",337558,"Trimethoprim 90 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",336956,"Indinavir 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",3364,"Didanosine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",3363,"Zalcitabine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",335921,"Rifampin 120 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",333409,"Trimethoprim 300 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",333250,"Rifampin 450 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",332959,"Pyrimethamine 12.5 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",332450,"Ritonavir 20 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",332349,"Aldesleukin 1.1 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",331952,"Flucytosine 0.01 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",331565,"valGANciclovir 450 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",331538,"lopinavir 80 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",331537,"Ritonavir 33.3 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",331536,"lopinavir 133 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",331497,"Trimethoprim 10 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",330837,"Nelfinavir 250 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",330816,"Didanosine 250 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",330786,"Didanosine 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",330498,"Stavudine 40 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",330440,"Ganciclovir 250 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",330321,"Didanosine 400 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",330320,"Didanosine 20 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",330319,"Didanosine 125 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",330243,"Stavudine 1 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",329867,"Indinavir 400 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",329866,"Indinavir 333 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",329485,"abacavir 300 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",329484,"abacavir 20 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",329267,"Amprenavir 15 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",329266,"Amprenavir 150 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",329265,"Amprenavir 50 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",329180,"Indinavir 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",328839,"Zalcitabine 0.75 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",328838,"Zalcitabine 0.375 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",328720,"Trimethoprim 1 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",328627,"Stavudine 30 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",328625,"Stavudine 20 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",328624,"Stavudine 15 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",328503,"Rifampin 60 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",328300,"Amphotericin B 0.03 MG/MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",328280,"Ganciclovir 50 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",323964,"Rifampin 600 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",323726,"Viread"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",322248,"Tenofovir disoproxil fumarate"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",318218,"sulfADIAZINE 33.4 MG/ML / Sulfamerazine 33.4 MG/ML / Sulfamethazine 33.4 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",317612,"Acyclovir 40 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",317538,"Zidovudine 10 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",317528,"Trimethoprim 80 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",317527,"Trimethoprim 16 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",317489,"Saquinavir 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",317488,"Ritonavir 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",317397,"lamiVUDine 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",317394,"Itraconazole 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",317374,"Fluconazole 40 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",317373,"Fluconazole 10 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",317359,"efavirenz 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",317150,"Ritonavir 100 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316992,"Lozenge"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316916,"Zidovudine 300 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316915,"Zidovudine 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316867,"Trimethoprim 8 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316865,"Trimethoprim 160 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316864,"Trimethoprim 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316739,"sulfADIAZINE 500 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316647,"Ritonavir 80 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316642,"Rifampin 300 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316641,"Rifampin 150 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316613,"Pyrimethamine 25 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316334,"Nevirapine 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316333,"Nevirapine 10 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316128,"lamiVUDine 5 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316127,"lamiVUDine 150 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316126,"lamiVUDine 10 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",316113,"Itraconazole 10 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315974,"Ganciclovir 500 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315941,"Flucytosine 500 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315940,"Flucytosine 250 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315939,"Fluconazole 50 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315938,"Fluconazole 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315937,"Fluconazole 2 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315936,"Fluconazole 150 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315935,"Fluconazole 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315853,"efavirenz 50 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315852,"efavirenz 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315807,"Didanosine 50 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315806,"Didanosine 25 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315805,"Didanosine 150 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315804,"Didanosine 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315760,"Dapsone 25 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315759,"Dapsone 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315674,"Cidofovir 75 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315374,"Amphotericin B 50 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315373,"Amphotericin B 5 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315372,"Amphotericin B 100 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315282,"Acyclovir 800 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315281,"Acyclovir 400 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315280,"Acyclovir 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",315217,"Stavudine 1 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",314007,"Ganciclovir 250 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",313961,"Didanosine 200 MG Chewable Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",313812,"Acyclovir 50 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",313760,"Zalcitabine 0.75 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",313759,"Zalcitabine 0.375 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",313566,"valGANciclovir 450 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",313137,"Sulfamethoxazole 80 MG/ML / Trimethoprim 16 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",313134,"Sulfamethoxazole 40 MG/ML / Trimethoprim 8 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",313110,"Stavudine 40 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",313109,"Stavudine 30 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",313108,"Stavudine 20 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",313107,"Stavudine 15 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",312821,"Rifampin 60 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",311943,"Nevirapine 10 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",311925,"Nelfinavir 0.05 MG/MG Oral Powder"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",311924,"Nelfinavir 250 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",311369,"lopinavir 80 MG/ML / Ritonavir 20 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",311368,"lopinavir 133 MG / Ritonavir 33.3 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",311205,"Itraconazole 10 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",311204,"Itraconazole 100 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",310988,"Indinavir 400 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",310987,"Indinavir 333 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",310986,"Indinavir 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",3108,"Dapsone"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",310495,"Immunoglobulin G, Human 120 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",310494,"Immunoglobulin G, Human 100 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",310442,"Ganciclovir 50 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",310353,"Fluconazole 40 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",310352,"Fluconazole 10 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",309873,"Didanosine 50 MG Chewable Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",309872,"Didanosine 25 MG Chewable Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",309871,"Didanosine 2.5 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",309869,"Didanosine 1.67 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",309868,"Didanosine 150 MG Chewable Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",309867,"Didanosine 1 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",309866,"Didanosine 100 MG Chewable Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",308206,"Amphotericin B 50 MG / Tetracycline 250 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",307816,"Aldesleukin 1.1 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",307730,"Acyclovir 40 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",307650,"abacavir 300 MG / Lamivudine 150 MG / Zidovudine 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",304959,"Valcyte"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",300195,"tenofovir disoproxil"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",285028,"abacavir 300 MG / Lamivudine 150 MG / Zidovudine 300 MG Oral Tablet [Trizivir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",285027,"Videx EC 250 MG Enteric Coated Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",284988,"Didanosine 400 MG Enteric Coated Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",284914,"Videx EC"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",284904,"Trizivir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",284756,"Kaletra"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",284640,"lopinavir / Ritonavir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",284620,"abacavir / Lamivudine / Zidovudine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",284587,"Valcyte 450 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",284500,"Videx EC 400 MG Enteric Coated Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",284499,"Videx EC 200 MG Enteric Coated Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",284498,"Videx 125 MG Enteric Coated Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",284185,"Didanosine 200 MG Enteric Coated Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",284184,"Didanosine 250 MG Enteric Coated Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",284183,"Didanosine 125 MG Enteric Coated Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",283103,"Indinavir 100 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",281,"Acyclovir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",28031,"Itraconazole"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",276237,"emtricitabine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",275891,"valGANciclovir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",261620,"Primsol"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",261457,"Baygam"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",261353,"Primsol 10 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",252619,"Amprenavir 15 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",252618,"Amprenavir 150 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",252617,"Amprenavir 50 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",252432,"Fluconazole 2 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",245837,"sulfADIAZINE 410 MG / Trimethoprim 90 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",244967,"Polymyxin B 10000 UNT/ML / Trimethoprim 1 MG/ML Ophthalmic Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",244413,"Amphotericin B 0.03 MG/MG Topical Ointment"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",242692,"lamiVUDine 5 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",242680,"abacavir 20 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",242679,"abacavir 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",240572,"isoniazid / Pyrazinamide / Rifampin Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",239240,"Amphotericin B 5 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",228656,"Amprenavir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",227633,"Ancobon"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",226026,"Octagam"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",224922,"Trimpex"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",224890,"Viramune"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",221052,"abacavir sulfate"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",221017,"Ziagen"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",220910,"Vitrasert"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",220772,"Venoglobulin-S 10%"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",220093,"Sulfamethoxazole / Trimethoprim Oral Suspension [Sulfatrim]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",220091,"Sulfatrim"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",219679,"Rifamate"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",219678,"Rifadin IV"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",219314,"Polymyxin B / Trimethoprim"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",219312,"Polygam S/D"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",217247,"Gammagard S/D"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",216937,"Epivir HBV"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",214671,"lamiVUDine / Zidovudine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",214662,"isoniazid / Pyrazinamide / Rifampin"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",214468,"DAUNOrubicin Liposomal"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",213706,"Zovirax 800 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",213694,"Zovirax 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",213484,"Epivir HBV 5 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",213483,"Epivir HBV 100 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",213461,"abacavir 20 MG/ML Oral Solution [Ziagen]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",213460,"abacavir 300 MG Oral Tablet [Ziagen]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",213405,"Viramune 10 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",213392,"Sustiva 50 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",213390,"Sustiva 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",213088,"3TC 150 MG / AZT 300 MG Oral Tablet [Combivir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",212118,"Viracept 250 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",211327,"Viramune 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",211248,"Vistide 75 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",209977,"Zovirax 5 % Topical Ointment"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",208631,"Trimpex 100 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",208451,"Polymyxin B 10000 UNT/ML / TMP 1 MG/ML Ophthalmic Solution [Polytrim]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",208416,"Bactrim 400 MG / 80 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",208406,"Sulfatrim 200/40 MG per 5 ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",207436,"Rifadin IV 60 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",207127,"Ancobon 500 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",207125,"Ancobon 250 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",207112,"Diflucan 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",207108,"Diflucan 150 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",207107,"Diflucan 100 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",207106,"Diflucan 50 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",206702,"Rifamate 150 MG-300 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",206698,"INH 50 MG / PZA 300 MG / Rifampin 120 MG Oral Tablet [Rifater]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",205853,"Polygam S/D 10 % Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",205849,"Iveegam 50 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",205847,"Venoglobulin-S 10 % 100 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",205743,"Cytovene 50 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",205328,"lamiVUDine 100 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",205292,"efavirenz 50 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",205291,"efavirenz 100 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",205290,"efavirenz 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",204569,"Immunoglobulin G Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",204534,"Zidovudine 10 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",204406,"Immunoglobulin G, Human 50 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",203760,"Proleukin"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",203748,"Zerit"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",203743,"Cytovene"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",203674,"Invirase"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",203608,"Crixivan"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",203218,"Pyrimethamine / Sulfadoxine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",202954,"Rimactane"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",202953,"Rifadin"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",202943,"Rescriptor"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",202826,"Sporanox"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",202813,"Diflucan"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",202807,"Septra"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",202791,"Retrovir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",201912,"Daraprim 25 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",201907,"Retrovir 100 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",201905,"Zovirax 400 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",201903,"Zovirax 40 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",201901,"Diflucan 40 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",201900,"Diflucan 10 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",201899,"Diflucan 2 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",201868,"Rifadin 300 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",201867,"Rifadin 150 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",200206,"Ganciclovir 500 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",200105,"Saquinavir 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",200082,"lamiVUDine 150 MG / Zidovudine 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199950,"Fluconazole 100 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199802,"Rifampin 450 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199756,"isoniazid 150 MG / Rifampin 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199755,"isoniazid 100 MG / Rifampin 150 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199748,"Flucytosine 500 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199747,"Fluconazole 50 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199746,"Fluconazole 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199745,"Fluconazole 150 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199663,"Zidovudine 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199620,"Rifampin 600 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199524,"Acyclovir 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199470,"Flucytosine 0.01 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199422,"Nevirapine 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199388,"Cidofovir 75 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199332,"Trimethoprim 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199264,"Amphotericin B 100 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199249,"Ritonavir 80 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199148,"lamiVUDine 10 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",199147,"lamiVUDine 150 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",198384,"isoniazid 50 MG / Pyrazinamide 300 MG / Rifampin 120 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",198352,"Zidovudine 100 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",198335,"Sulfamethoxazole 800 MG / Trimethoprim 160 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",198334,"Sulfamethoxazole 400 MG / Trimethoprim 80 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",198332,"Trimethoprim 100 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",198229,"Pyrimethamine 25 MG / Sulfadoxine 500 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",198228,"sulfADIAZINE 500 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",198203,"isoniazid 150 MG / Rifampin 300 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",198202,"Rifampin 300 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",198201,"Rifampin 150 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",198182,"Pyrimethamine 25 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197703,"Flucytosine 500 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197702,"Flucytosine 250 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197701,"Fluconazole 50 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197700,"Fluconazole 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197699,"Fluconazole 150 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197698,"Fluconazole 100 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197558,"Dapsone 25 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197557,"Dapsone 100 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197368,"Amphotericin B 30 MG/ML Topical Lotion"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197367,"Amphotericin B 30 MG/ML Topical Cream"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197313,"Acyclovir 800 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197312,"Acyclovir 0.05 MG/MG Topical Ointment"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197311,"Acyclovir 400 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",197310,"Acyclovir 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",196479,"Norvir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",196478,"Epivir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",195088,"lopinavir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",195085,"efavirenz"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",195084,"Sustiva"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",192254,"Combivir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",190548,"tipranavir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",190521,"abacavir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",153652,"Zerit 1 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",153530,"Octagam 5 % Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",153128,"Crixivan 400 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",153127,"Crixivan 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",152971,"Norvir 80 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",152970,"Norvir 100 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",152944,"Zerit 40 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",152943,"Zerit 30 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",152942,"Zerit 20 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",152941,"Zerit 15 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",152932,"Epivir 10 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",152931,"Epivir 150 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",152854,"Sporanox 10 MG/ML Oral Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",152772,"Retrovir 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",152606,"DaunoXome"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",152535,"Zovirax"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",152494,"Videx"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",151583,"Daraprim"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",151399,"Bactrim"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1486841,"ISENTRESS 20 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1486840,"ISENTRESS Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1486839,"raltegravir Oral Suspension [ISENTRESS]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1486838,"raltegravir 20 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1486821,"raltegravir 20 MG/ML [ISENTRESS]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1486819,"raltegravir 20 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1486579,"raltegravir Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1486578,"raltegravir Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1426680,"Immunoglobulin G, Human"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1423662,"Acyclovir 50 MG Buccal Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1423661,"Acyclovir Buccal Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1423660,"Acyclovir Buccal Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1423659,"Acyclovir 50 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",142152,"Delavirdine Mesylate"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1421195,"raltegravir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1421185,"raltegravir Chewable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",142118,"Sulfamethoxazole 100 MG / Trimethoprim 20 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1421179,"raltegravir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",142061,"Immunoglobulin G, Human 160 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",141859,"Acyclovir 50 MG/ML Topical Cream"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",139896,"enfuvirtide"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1373747,"24 HR Viramune 100 MG Extended Release Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1373746,"Nevirapine 100 MG [Viramune]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1373745,"24 HR Nevirapine 100 MG Extended Release Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1364428,"Bivigam 10 % Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1364427,"Bivigam Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1364426,"Immunoglobulin G Injectable Solution [Bivigam]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1364425,"Immunoglobulin G, Human 100 MG/ML [Bivigam]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1364424,"Bivigam"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1359271,"Prezista 800 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1359270,"darunavir 800 MG [Prezista]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1359269,"darunavir 800 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1359268,"darunavir 800 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",134527,"Nelfinavir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",134526,"Viracept"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306298,"Stribild (cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / Tenofovir disoproxil fumarate 300) Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306297,"Stribild Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306296,"Stribild Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306295,"cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil Oral Tablet [Stribild]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306294,"cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / Tenofovir disoproxil fumarate 300 MG [Stribild]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306293,"Stribild"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306292,"cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306291,"cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306290,"cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306289,"cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306288,"cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306287,"elvitegravir 150 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306286,"elvitegravir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306285,"cobicistat 150 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1306284,"cobicistat"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1297007,"ISENTRESS Chewable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1296770,"Viracept Oral Powder Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1295865,"Viread Oral Powder Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1295588,"Didanosine Chewable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1295148,"tenofovir disoproxil Oral Powder Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1295040,"Nelfinavir Oral Powder Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1294702,"Lozenge Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1294701,"Buccal Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",128790,"Polytrim"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250723,"Intelence 25 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250722,"etravirine 25 MG [Intelence]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250721,"etravirine 25 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250720,"etravirine 25 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250672,"Lidovir (acyclovir 4 % / lidocaine hydrochloride 4 % ) Topical Ointment"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250671,"Lidovir Topical Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250670,"Acyclovir / Lidocaine Topical Ointment [Lidovir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250669,"Acyclovir 0.04 MG/MG / Lidocaine Hydrochloride 0.04 MG/MG [Lidovir]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250668,"Lidovir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250667,"Acyclovir 0.04 MG/MG / Lidocaine Hydrochloride 0.04 MG/MG Topical Ointment"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250666,"Acyclovir / Lidocaine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250665,"Acyclovir / Lidocaine Topical Ointment"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250664,"Acyclovir / Lidocaine Topical Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1250663,"Acyclovir 0.04 MG/MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243346,"Viread 0.04 MG/MG Oral Powder"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243345,"tenofovir disoproxil Oral Powder [Viread]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243344,"Tenofovir disoproxil fumarate 0.04 MG/MG [Viread]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243343,"Tenofovir disoproxil fumarate 0.04 MG/MG Oral Powder"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243342,"tenofovir disoproxil Oral Powder"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243341,"Tenofovir disoproxil fumarate 0.04 MG/MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243330,"Viread 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243329,"Tenofovir disoproxil fumarate 200 MG [Viread]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243328,"Tenofovir disoproxil fumarate 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243327,"Tenofovir disoproxil fumarate 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243326,"Viread 150 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243325,"Tenofovir disoproxil fumarate 150 MG [Viread]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243324,"Tenofovir disoproxil fumarate 150 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243323,"Tenofovir disoproxil fumarate 150 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243229,"Viread 250 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243228,"Tenofovir disoproxil fumarate 250 MG [Viread]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243227,"Tenofovir disoproxil fumarate 250 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1243226,"Tenofovir disoproxil fumarate 250 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1236632,"Prezista 100 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1236631,"Prezista Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1236630,"darunavir Oral Suspension [Prezista]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1236629,"darunavir 100 MG/ML [Prezista]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1236628,"darunavir 100 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1236627,"darunavir Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1236626,"darunavir Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1236625,"darunavir 100 MG/ML"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1235595,"ISENTRESS 25 MG Chewable Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1235594,"raltegravir 25 MG [ISENTRESS]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1235593,"raltegravir 25 MG Chewable Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1235592,"raltegravir 25 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1235591,"ISENTRESS 100 MG Chewable Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1235590,"raltegravir Chewable Tablet [ISENTRESS]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1235589,"raltegravir 100 MG [ISENTRESS]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1235588,"raltegravir 100 MG Chewable Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1235587,"raltegravir Chewable Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1235586,"raltegravir 100 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1232617,"DaunoXome 2 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1232616,"DAUNOrubicin Liposomal Injectable Solution [DaunoXome]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1232615,"DAUNOrubicin Liposomal 2 MG/ML [DaunoXome]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1232418,"Onmel 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1232417,"Onmel Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1232416,"Onmel Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1232415,"Itraconazole Oral Tablet [Onmel]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1232414,"Itraconazole 200 MG [Onmel]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1232413,"Onmel"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1187773,"Venoglobulin-S 10% Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1187668,"Zirgan Ophthalmic Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1187397,"Vivaglobin Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1187271,"Zerit Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1187270,"Zerit Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1187269,"Zerit Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1187176,"Vitrasert Drug Implant Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1187173,"Vistide Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1187140,"Valcyte Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1187139,"Valcyte Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1187138,"Valcyte Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186974,"Viread Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186973,"Viread Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186809,"Viramune Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186808,"Viramune Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186807,"Viramune Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186804,"Viracept Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186803,"Viracept Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186590,"Videx Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186589,"Videx Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186588,"Videx Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186587,"Videx EC Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186586,"Videx EC Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186580,"Victrelis Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186579,"Victrelis Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186466,"Zovirax Topical Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186465,"Zovirax Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186464,"Zovirax Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186463,"Zovirax Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186419,"Xerese Topical Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186158,"Lexiva Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186157,"Lexiva Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1186156,"Lexiva Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1185615,"Truvada Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1185614,"Truvada Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1185594,"Trizivir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1185593,"Trizivir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1185473,"Sustiva Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1185472,"Sustiva Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1184733,"Rimactane Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1184732,"Rimactane Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1184719,"Rifater Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1184718,"Rifater Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1184717,"Rifamate Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1184716,"Rifamate Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1184715,"Rifadin Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1184714,"Rifadin Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1184711,"Rifadin IV Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1184364,"Trimpex Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1184363,"Trimpex Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1184053,"Polytrim Ophthalmic Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1183776,"Sulfatrim Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1183775,"Sulfatrim Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1183529,"Polygam S/D Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1183051,"Reyataz Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1183050,"Reyataz Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1182542,"Retrovir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1182541,"Retrovir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1182540,"Retrovir Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1182538,"Retrovir Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1181886,"Rescriptor Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1181885,"Rescriptor Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1180698,"Proleukin Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1180526,"Octagam Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1180165,"Septra Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1180164,"Septra Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1180159,"Septra Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1178922,"Privigen Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1178271,"Primsol Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1178270,"Primsol Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1177776,"Sporanox Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1177775,"Sporanox Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1177774,"Sporanox Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1177773,"Sporanox Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1177659,"Prezista Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1177658,"Prezista Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1177580,"Norvir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1177579,"Norvir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1177578,"Norvir Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1175949,"Emtriva Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1175948,"Emtriva Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1175947,"Emtriva Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1175770,"Carimune Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1175568,"Ancobon Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1175567,"Ancobon Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1175395,"Gamunex Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1175390,"Gammar Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1175389,"Gammaplex Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1175388,"Gammaked Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1175387,"Gammagard S/D Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1175386,"Gammagard Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1175381,"GamaSTAN Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1174702,"Fuzeon Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1174489,"Cytovene Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1173456,"Invirase Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1173455,"Invirase Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1173437,"Intelence Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1173436,"Intelence Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1173062,"Crixivan Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1173061,"Crixivan Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1172892,"Atripla Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1172891,"Atripla Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1172011,"Incivek Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1172010,"Incivek Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1171272,"Hizentra Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1169951,"Aczone Topical Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1169034,"Flebogamma Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168816,"DaunoXome Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168647,"Baygam Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168601,"Aptivus Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168600,"Aptivus Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168599,"Aptivus Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168552,"Kaletra Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168549,"Kaletra Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168546,"Kaletra Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168234,"Epzicom Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168178,"Diflucan Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168177,"Diflucan Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168176,"Diflucan Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168168,"Daraprim Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1168167,"Daraprim Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1167959,"Bactrim Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1167956,"Bactrim Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1167643,"Epzicom Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1167631,"Epivir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1167630,"Epivir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1167629,"Epivir Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1167628,"Epivir HBV Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1167627,"Epivir HBV Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1167626,"Epivir HBV Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1167548,"Diflucan Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1167417,"Complera Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1167416,"Complera Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1167184,"Iveegam Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1166891,"Combivir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1166890,"Combivir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1166639,"IsonaRif Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1166638,"IsonaRif Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1166567,"ISENTRESS Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1166566,"ISENTRESS Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1165666,"fosamprenavir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1165665,"fosamprenavir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1165662,"fosamprenavir Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1165487,"Ritonavir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1165486,"Ritonavir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1165485,"Ritonavir Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1165466,"Rifampin Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1165465,"Rifampin Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1165463,"Rifampin Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1164168,"Pyrimethamine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1164167,"Pyrimethamine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1164166,"Pyrimethamine / Sulfadoxine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1164165,"Pyrimethamine / Sulfadoxine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163994,"valGANciclovir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163993,"valGANciclovir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163992,"valGANciclovir Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163920,"Ganciclovir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163919,"Ganciclovir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163918,"Ganciclovir Ophthalmic Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163917,"Ganciclovir Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163916,"Ganciclovir Drug Implant Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163859,"lopinavir / Ritonavir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163858,"lopinavir / Ritonavir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163857,"lopinavir / Ritonavir Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163784,"etravirine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163783,"etravirine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163061,"abacavir / lamiVUDine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163060,"abacavir / lamiVUDine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163059,"abacavir / lamiVUDine / Zidovudine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163058,"abacavir / lamiVUDine / Zidovudine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163029,"Zidovudine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163028,"Zidovudine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163027,"Zidovudine Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163026,"Zidovudine Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163024,"Zalcitabine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1163023,"Zalcitabine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162984,"Sulfamethoxazole / Trimethoprim Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162983,"Sulfamethoxazole / Trimethoprim Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162982,"Sulfamethoxazole / Trimethoprim Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162981,"Sulfamethoxazole / Trimethoprim Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162820,"lamiVUDine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162819,"lamiVUDine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162818,"lamiVUDine Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162817,"lamiVUDine / Zidovudine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162816,"lamiVUDine / Zidovudine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162350,"sulfADIAZINE Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162349,"sulfADIAZINE Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162344,"sulfADIAZINE / Trimethoprim Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162343,"sulfADIAZINE / Trimethoprim Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162340,"sulfADIAZINE / Sulfamerazine / Sulfamethazine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162339,"sulfADIAZINE / Sulfamerazine / Sulfamethazine Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162111,"tipranavir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162110,"tipranavir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1162109,"tipranavir Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161890,"enfuvirtide Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161889,"emtricitabine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161888,"emtricitabine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161887,"emtricitabine Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161886,"emtricitabine / tenofovir disoproxil Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161885,"emtricitabine / tenofovir disoproxil Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161745,"Stavudine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161744,"Stavudine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161743,"Stavudine Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161490,"tenofovir disoproxil Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161489,"tenofovir disoproxil Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161349,"isoniazid / Rifampin Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161348,"isoniazid / Rifampin Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161347,"isoniazid / Pyrazinamide / Rifampin Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161346,"isoniazid / Pyrazinamide / Rifampin Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161304,"emtricitabine / Rilpivirine / tenofovir disoproxil Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161303,"emtricitabine / Rilpivirine / tenofovir disoproxil Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161290,"efavirenz Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161289,"efavirenz Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161287,"efavirenz / emtricitabine / tenofovir disoproxil Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161286,"efavirenz / emtricitabine / tenofovir disoproxil Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161285,"efavirenz / lamiVUDine / tenofovir disoproxil Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1161284,"efavirenz / lamiVUDine / tenofovir disoproxil Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1160885,"telaprevir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1160884,"telaprevir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1160240,"Flucytosine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1160239,"Flucytosine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1160238,"Flucytosine Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1160237,"Fluconazole Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1160236,"Fluconazole Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1160235,"Fluconazole Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1160234,"Fluconazole Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1159901,"Polymyxin B / Trimethoprim Ophthalmic Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1159778,"Itraconazole Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1159777,"Itraconazole Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1159776,"Itraconazole Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1159775,"Itraconazole Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1158827,"Trimethoprim Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1158826,"Trimethoprim Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1158825,"Trimethoprim Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1158094,"Nevirapine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1158093,"Nevirapine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1158092,"Nevirapine Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1157612,"Saquinavir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1157611,"Saquinavir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1157537,"Nelfinavir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1157536,"Nelfinavir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1157185,"darunavir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1157184,"darunavir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1156307,"Indinavir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1156306,"Indinavir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1156296,"Immunoglobulin G Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1155330,"boceprevir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1155329,"boceprevir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1154611,"Aldesleukin Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1154365,"Atazanavir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1154364,"Atazanavir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1153463,"Acyclovir Topical Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1153462,"Acyclovir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1153461,"Acyclovir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1153460,"Acyclovir Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1153458,"Acyclovir Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1153457,"Acyclovir / Hydrocortisone Topical Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1153204,"Amprenavir Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1153203,"Amprenavir Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1153202,"Amprenavir Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1152917,"Amphotericin B Topical Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1152915,"Amphotericin B Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1152914,"Amphotericin B Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1152913,"Amphotericin B Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1152910,"Amphotericin B / Tetracycline Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1152909,"Amphotericin B / Tetracycline Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1152174,"Delavirdine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1152173,"Delavirdine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1152145,"DAUNOrubicin Liposomal Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1152142,"Dapsone Topical Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1151859,"Dapsone Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1151858,"Dapsone Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1151855,"Dapsone / Pyrimethamine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1151854,"Dapsone / Pyrimethamine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1151776,"Cidofovir Injectable Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1151172,"Didanosine Pill"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1151171,"Didanosine Oral Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1151170,"Didanosine Oral Liquid Product"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1147337,"Complera (emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG) Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1147336,"emtricitabine 200 MG / Rilpivirine 25 MG / Tenofovir disoproxil fumarate 300 MG [Complera]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1147334,"emtricitabine 200 MG / Rilpivirine 25 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1145805,"emtricitabine / Rilpivirine / tenofovir disoproxil Oral Tablet [Complera]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1145803,"Complera"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1145801,"emtricitabine / Rilpivirine / tenofovir disoproxil"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1145800,"emtricitabine / Rilpivirine / tenofovir disoproxil Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",114289,"Indinavir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",11413,"Zidovudine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1117551,"Gammaked 10 % Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1117550,"Immunoglobulin G Injectable Solution [Gammaked]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1117549,"Immunoglobulin G, Human 100 MG/ML [Gammaked]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1117548,"Gammaked"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102282,"Incivek 375 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102281,"telaprevir Oral Tablet [Incivek]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102280,"telaprevir 375 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102279,"telaprevir Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102271,"Rilpivirine 25 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102270,"Rilpivirine"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102266,"telaprevir 375 MG [Incivek]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102265,"Incivek"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102262,"telaprevir 375 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102261,"telaprevir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102136,"Victrelis 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102135,"boceprevir Oral Capsule [Victrelis]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102134,"boceprevir 200 MG [Victrelis]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102133,"Victrelis"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102132,"boceprevir 200 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102131,"boceprevir Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102130,"boceprevir 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1102129,"boceprevir"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1095715,"24 HR Viramune 400 MG Extended Release Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1095714,"Nevirapine Extended Release Tablet [Viramune]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1095713,"Nevirapine 400 MG [Viramune]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1095712,"24 HR Nevirapine 400 MG Extended Release Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1095711,"Nevirapine Extended Release Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1095710,"Nevirapine 400 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",108449,"Trimethoprim 10 MG/ML Oral Suspension"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",108396,"Retrovir 10 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",10831,"Sulfamethoxazole / Trimethoprim"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",10829,"Trimethoprim"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",106876,"isoniazid / Rifampin"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",105648,"Proleukin 1.1 MG/ML Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",105337,"Dapsone 100 MG / Pyrimethamine 12.5 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",105295,"Rimactane 300 MG Oral Capsule"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1052660,"Intelence 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1052659,"etravirine 200 MG [Intelence]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1052658,"etravirine 200 MG Oral Tablet"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1052657,"etravirine 200 MG"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",10171,"sulfADIAZINE"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1009212,"Flebogamma 10 % Injectable Solution"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1009211,"Immunoglobulin G, Human 100 MG/ML [Flebogamma]"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1008789,"efavirenz / lamiVUDine / tenofovir disoproxil"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1008145,"emtricitabine / tenofovir disoproxil"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1007804,"Acyclovir / Hydrocortisone"
"2.16.840.1.113883.6.88","RxNorm","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",1007761,"efavirenz / emtricitabine / tenofovir disoproxil"
"2.16.840.1.113883.6.88","RxNorm","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-Treatment-RxNorm",151358,"Antabuse"
"2.16.840.1.113883.6.96","SNOMED-Clinical Terms","Drug abuse information sensitivity","Cocaine-Abuse-ICD-9-SNOMED",417877006,"Cocaine - pharmaceutical (substance)"
"2.16.840.1.113883.6.96","SNOMED-Clinical Terms","HIV/AIDS information sensitivity","HIV-Related-Disorders-ICD-9-SNOMED",420721002,"AIDS-associated disorder (disorder)"
"2.16.840.1.113883.6.96","SNOMED-Clinical Terms","HIV/AIDS information sensitivity","HIV-Related-Medications-RxNorm",111880001,"Acute HIV"
"2.16.840.1.113883.6.96","SNOMED-Clinical Terms","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",66214007,"Substance Abuse"
"2.16.840.1.113883.6.96","SNOMED-Clinical Terms","Alcohol Abuse and Alcoholism Information","Alcohol-Abuse-ICD-9-SNOMED",15167005,"Alcohol abuse (disorder)"
"2.16.840.1.113883.6.96","SNOMED-Clinical Terms","SICKLE CELL","SICKLE CELL-SNOMED",16402000,"Sickle cell trait (disorder)"
"2.16.840.1.113883.6.103","ICD-9-CM","SICKLE CELL","SICKLE CELL-ICD-9-CM",282.5,"Sickle cell trait (disorder)"
"2.16.840.1.113883.6.96","SNOMED-Clinical Terms","ACS","Colon Cancer-SNOMED",93761005,"Primary malignant neoplasm of colon"